Fluorescent chemosensors for the detection of biological amines by Klockow, Jessica L.
  
 
FLUORESCENT CHEMOSENSORS FOR THE DETECTION  
OF BIOLOGICAL AMINES 
_______________________________________ 
A Dissertation 
presented to 
the Faculty of the Graduate School 
at the University of Missouri-Columbia 
_______________________________________________________ 
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy 
_____________________________________________________ 
by 
JESSICA L. KLOCKOW 
Dr. Timothy E. Glass, Dissertation Supervisor 
 
 
 
 
 
  
The undersigned, appointed by the dean of the Graduate School, have examined the 
dissertation entitled 
FLUORESCENT CHEMOSENSORS FOR THE DETECTION OF  
BIOLOGICAL AMINES 
presented by Jessica L. Klockow, 
a candidate for the degree of doctor of philosophy 
and hereby certify that, in their opinion, it is worthy of acceptance. 
 
 
__________________________________________ 
Professor Timothy E. Glass 
 
__________________________________________ 
Professor Kent S. Gates 
 
__________________________________________ 
Professor Michael A. Harmata 
 
__________________________________________ 
Professor Kevin D. Gillis 
 
ii 
 
ACKNOWLEDGEMENTS 
There are numerous people that I need to thank for support and guidance 
throughout my tenure as a graduate student. 
 Thank you to my group members: Jae Lee, Shaohui Zhang, Chun Ren, Yuksel 
Alan, Chad Cooley, Xiaole Shao, Patrick Cavins, Nicholas Cooley, Wanjun Zhou, C.W. 
Littlefield, Kang Han, Tam Tran, and Le Zhang. I appreciate your talents, unfailing 
humor, and above all, your friendship for the past many years. I wish you only the best in 
the years to come, whatever they may hold. 
 Thank you to Drs. Lever, Gates, Harmata, and Gillis for your thoughtful direction 
in matters of teaching, chemistry, and professional development. You lead by example 
showing enthusiasm for your craft and compassion for your students. You have inspired 
me to work hard, do what I love, and pay it forward. Please know how valued you are. 
 I owe a debt of gratitude to Dr. Tim Glass who mentored me on laboratory 
techniques, data analysis, academia politics, personal adversities, and more.  Thank you 
for every meeting in which you ignored the ringing phone and for every bout of failure 
that you met with optimism. Given my professional and personal circumstances, I am 
very glad to have had you as an adviser. 
 Most importantly, thank you to my family and to my husband, Ken, for believing 
in me and encouraging me to push the limits of my abilities. Thank you for motivating 
during the slumps and celebrating the victories.   
 
 
 
iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS.......................................................................................…...ii 
LIST OF FIGURES………………………………………………………...……….......vi 
LIST OF TABLES…………………………………………………………………........xi 
ABSTRACT……………………………………………………………………….....…xii 
CHAPTER ONE: Introduction…………………………………………………..…..... 1 
1.1 Fluorescence Sensing.....................................................................................................1 
1.1.1 Molecular Recognition….……………………………………….…….…….1 
1.1.2 Fluorescence Basics........................................................................................3 
1.1.3 Mechanisms of Fluorescence Modulation……………………….….………5 
1.2 Detection of Amino Acids...........................................................................................11 
1.3 Detection of Neurotransmitters....................................................................................14 
1.4 Monitoring Exocytosis.................................................................................................20 
1.4.1 FM Dyes.......................................................................................................21 
1.4.2 SynaptopHluorins.........................................................................................22 
1.4.3 False Fluorescent Neurotransmitters (FFNs)................................................23 
CHAPTER TWO: A Fluorescent Chemosensor for Kynurenine……………..…….26 
2.1 Overview......……………...………………………………………………….………26 
2.2 Coumarin Dimers .............................................………………………………...……28 
2.3 Coumarin Monomer .......................................………………………………….……30 
CHAPTER THREE: Visualizing Exocytosis with Sulfonamide Coumarins….....…36 
3.1 Background………………………………………………………………………......36 
3.2 Molecular Logic Gates.................................................................................................37 
iv 
 
3.3 NeuroSensors……………………….……………………………………………......38 
3.4 ExoSensors…………………………….……………………………………………..41 
3.5 Design of ExoSensors…………………………………………………………..……42 
3.6 Synthesis of ExoSensors..............................................................................................46 
3.7 Spectroscopic Results..................................................................................................52 
3.7.1 pH Titrations…………………………………………………………….…52 
3.7.2 Analyte Titrations…………………………………………………….……54 
3.7.3 Response to Exocytosis……………………………………………….……58 
3.8 Cellular Analysis..........................................................................................................59 
CHAPTER FOUR: Three-Input Molecular Logic Gates for Glutamate & Zinc 
Corelease............................................................................................................................63 
4.1 Background…………………………………………………………………………..63 
4.2 Previous Work……………………………………………………………………….65 
4.3 Sensor Design…………………………………………………………………….….66 
4.4 Synthesis…………………………………………………………………….……….67 
4.5 Titrations………………………………………………………………………..……69 
APPENDIX: Experimental Procedures and Characterization Data…………………….76 
Part I. General Information…………………………………………………………....…76 
Part II. Spectroscopic Studies….…………………………………………………...……76 
Part III. Binding Constant Determination......………….........................……….......……97 
Part IV. pKa Determination…….....................………………………….……………..…99 
Part V. Cellular Analyses ………………………………………………………………100 
Part VI. Synthetic Procedures and Characterization Data………………………...……102 
v 
 
REFERENCES…………………..………………………………………………..…...142 
VITA……………………………………………………………………………...........150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF FIGURES 
Figure 1-1: Reversible host-guest interactions….……………………………………..…1 
Figure 1-2: Covalent analyte recognition motifs…………………………………………2 
Figure 1-3: Jablonski diagram……….………………………………………………...…3 
Figure 1-4: Stokes shift………………………………………………………………...…4 
Figure 1-5: Extrinsic fluorophores………………………………………………………..5 
Figure 1-6: Spectral overlap of FRET pairs………..……………………………....…..…6 
Figure 1-7: FRET sensor for nucleoside polyphosphates..……………………….....……8 
Figure 1-8: Acceptor- and donor-excited PET..........................……………...………..…9 
Figure 1-9: PET sensor for mercury................................................…………………...…9 
Figure 1-10: Effect of EDGs and EWGs on absorption........................………...………10 
Figure 1-11: ICT BODIPY-based sensor for cadmium.............……………………...…11 
Figure 1-12: Examples of amino acid detection.......................…………………………12 
Figure 1-13: Covalent interaction of coumarin aldehydes with amino acids…...………13 
Figure 1-14: UV/Vis & fluorescence spectra of sensor 1 with glycine............................14 
Figure 1-15: Neurotransmitter uptake into synaptic vesicles………………….......……15 
Figure 1-16: Molecular structures of amine neurotransmitters………………....………15 
Figure 1-17: Detection of dopamine using cyclic voltammetry………………...………16 
Figure 1-18: GluSnFR biosensor.......………………..………………………….………17 
Figure 1-19: Snifit biosensor..............………………..…………………………………18 
Figure 1-20: Chemical sensors for neurotransmitters…………………………...………19 
Figure 1-21: Quenching ability of neurotransmitters.…………………………..………19 
Figure 1-22: Coumarin aldehyde catecholamine sensors…………………….....………20 
vii 
 
Figure 1-23: Structure and mechanism of FM dyes..……………………………...……21  
Figure 1-24: Amino acid sequences for GFP and phluorin………………………..……22 
Figure 1-25: Structures of FFN dyes………………..……………………………..……23 
Figure 1-26: Summary of indirect methods for monitor exo- & endocytosis..................24 
*** 
Figure 2-1: The kynurenine pathway……..………………………………………..……27 
Figure 2-2: Binding of glycine to coumarin aldehydes.............................…………...…28 
Figure 2-3: Synthesis of O-linked dimers...…………………………………………..…29 
Figure 2-4: Synthesis of N-linked dimers……...……………………………………..…30 
Figure 2-5: Synthesis of coumarin monomer….………………………………………..30 
Figure 2-6: UV/vis & fluorescence spectra of sensor 14 with kynurenine…...……........31 
Figure 2-7: UV/vis spectra of sensor 14 with various analytes……………………........32 
Figure 2-8: UV/vis spectra & regression curve of sensor 14 pH titration........................33 
Figure 2-9: Competitive binding study of sensor 14………………………………........35 
*** 
Figure 3-1: Symbols & truth tables for various logic operations...........…………..........38 
Figure 3-2: Logic gate and truth table for NeuroSensors…………………………….....39 
Figure 3-3: Confocal fluorescence microscopy of NeuroSensor 521……………….......40 
Figure 3-4: Pictoral representation of selective binding of NeuroSensor 521..……........41 
Figure 3-5: Logic gate and truth table for two-input ExoSensors………………………42 
Figure 3-6: Sensing mechanism of ExoSensors..........……………………………….....44 
Figure 3-7: Neurotransmitter binding and deprotonation of ExoSensors………….........45 
Figure 3-8: Synthesis using carbamate protecting groups..…………………………......46 
viii 
 
Figure 3-9: The carbamate-protected coumarin is deactivated……………………….....47 
Figure 3-10: Synthesis using allyl protecting groups........……………………………...47 
Figure 3-11: Rearranged products from the Pechmann cyclization..…………………...48 
Figure 3-12: Formylation of the allyl-protected aminocoumarin…………………….....49 
Figure 3-13: Claisen condensation of an aryl sulfonamide...............................………...50 
Figure 3-14: Synthesis by oxidizing to the aldehyde................................……………....50 
Figure 3-15: Synthesis using Buchwald-Hartwig coupling..............………....................51 
Figure 3-16: UV/vis & fluorescence spectra of ES517  pH titration ..….........................53 
Figure 3-17: UV/vis & fluorescence spectra of ES517-glutamate pH titration................54 
Figure 3-18: UV/vis & fluorescence spectra of ES517 adding glutamate........................56 
Figure 3-19: Fluorescence enhancements of ES517 simulating exocytosis.....................57 
Figure 3-20: Relationship between sensor pKa and fluorescence upon exocytosis..........59 
Figure 3-21: ES517 in live cells...............…………………………………....................61 
*** 
Figure 4-1: Zn
2+
-mediated amyloid-β oligomerization……………………………....…64 
Figure 4-2: Molecular logic gates for neuronal imaging…………………………….….66 
Figure 4-3: Logic gate & truth table for three-input AND gates..……………………....67 
Figure 4-4: Synthesis of hydroxysalicylaldehyde starting material....……………….….68 
Figure 4-5: Second part of synthesis for three-input AND gates...…………………......69 
Figure 4-6: UV/vis & fluorescence spectra of ES470 adding glutamate…………......…70 
Figure 4-7: UV/vis & fluorescence spectra of ES470-glutamate adding Zn
2+…….……71 
Figure 4-8: Relative fluorescence intensities & truth table for ES470.............……....…73 
*** 
ix 
 
Figure A-1: UV/vis & fluorescence spectra of compound 41 adding glutamate..............77 
Figure A-2: UV/vis & fluorescence spectra of compound 41 adding norepinephrine.....77 
Figure A-3: UV/vis & fluorescence spectra of compound 41 adding dopamine..............78 
Figure A-4: UV/vis & fluorescence spectra of compound 41 adding serotonin..............78 
Figure A-5: Fluorescence spectra of ES517 adding GABA.............................................79 
Figure A-6: Fluorescence spectra of ES517 adding glycine.............................................79 
Figure A-7: Fluorescence spectra of ES517 adding norepinephrine................................80 
Figure A-8: Fluorescence spectra of ES517 adding dopamine.........................................80 
Figure A-9: Fluorescence spectra of ES517 adding serotonin.........................................81 
Figure A-10: UV/vis & fluorescence spectra of compound 28 adding glutamate............81 
Figure A-11: UV/vis & fluorescence spectra of compound 28 adding norepinephrine...82 
Figure A-12: UV/vis & fluorescence spectra of compound 28 adding dopamine............82 
Figure A-13: UV/vis & fluorescence spectra of compound 28 adding serotonin............83 
Figure A-14: UV/vis & fluorescence spectra of compound 43 adding glutamate............83 
Figure A-15: UV/vis & fluorescence spectra of compound 43 adding norepinephrine...84 
Figure A-16: UV/vis & fluorescence spectra of compound 43 adding dopamine............84 
Figure A-17: UV/vis & fluorescence spectra of compound 43 adding serotonin............85 
Figure A-18: UV/vis & fluorescence spectra of compound 44 adding glutamate............85 
Figure A-19: UV/vis & fluorescence spectra of compound 44 adding norepinephrine...86 
Figure A-20: UV/vis & fluorescence spectra of compound 44 adding dopamine............86 
Figure A-21: UV/vis & fluorescence spectra of compound 44 adding serotonin............87 
Figure A-22: UV/vis & fluorescence spectra of compound 56a adding glutamate..........87 
Figure A-23: UV/vis & fluorescence spectra of compound 56b adding glutamate.........88 
x 
 
Figure A-24: UV/vis & fluorescence spectra of compound 56d adding glutamate.........88 
Figure A-25: Fluorescence spectra of 56a-glutamate adding zinc...................................89 
Figure A-26: Fluorescence spectra of 56b-glutamate adding zinc...................................89 
Figure A-27: Fluorescence spectra of 56d-glutamate adding zinc...................................90 
Figure A-28: Fluorescence spectra of ES470-glutamate adding zinc...............................90 
Figure A-29: Fluorescence spectra of ES470 adding glycine...........................................91 
Figure A-30: Fluorescence spectra of ES470 adding aspartate........................................91 
Figure A-31: Fluorescence spectra of ES470 adding GABA...........................................92 
Figure A-32: Fluorescence spectra of ES470 adding butylamine....................................92 
Figure A-33: UV/vis & fluorescence spectra of compound 28 pH titration.....................93 
Figure A-34: UV/vis & fluorescence spectra of compound 43 pH titration.....................93 
Figure A-35: UV/vis & fluorescence spectra of compound 44 pH titration.....................94 
Figure A-36: UV/vis & fluorescence spectra of compound 41 pH titration.....................94 
Figure A-37: UV/vis & fluorescence spectra of compound 56a pH titration...................95 
Figure A-38: UV/vis & fluorescence spectra of compound 56b pH titration..................95 
Figure A-39: UV/vis & fluorescence spectra of ES470 pH titration................................96 
Figure A-40: UV/vis & fluorescence spectra of compound 56d pH titration..................96 
Figure A-41: UV/vis spectra & regression curve for compound 40.................................97 
Figure A-42: Sample binding isotherm ...........................................................................98 
Figure A-43: Sample regression curve from a pH titration..............................................99 
 
 
 
xi 
 
LIST OF TABLES 
Table 1-1: Spectroscopic & binding results of sensor 1………………………………...14 
*** 
Table 2-1: Spectroscopic & binding results of sensor 14…………………………….....34 
*** 
Table 3-1: Absorbance & pKa values of two-input ExoSensors.......................................54 
Table 3-2: Spectroscopic & binding results of two-input ExoSensors.............................55 
Table 3-3: Spectroscopic & binding results of ES517 with various amines.....................57 
*** 
Table 4-1: Spectroscopic & binding results of three-input ExoSensors...........................72 
Table 4-2: Spectroscopic & binding results of ES470 with various amines.....................74 
 
 
 
 
 
 
 
 
 
xii 
 
ABSTRACT 
Chemical sensing has become an important field for the study of bioanalytes and 
provides key information pertaining to disease pathogenesis, and the physiological 
mechanisms underlying cellular processes. Discussed herein is a brief introduction to 
fluorescence methods for bioanalyte detection along with the design and synthesis of 
novel chemical sensors for important bioamines. 
First, we report a chemical sensor for kynurenine, a molecule known to contribute 
to tumor growth and the development of neurodegenerative diseases. Several coumarin 
dimers were developed for the two-point binding of kynurenine, but showed poor 
solubility in aqueous media. Later, a coumarin monomer was developed that showed high 
selectivity for kynurenine and a pronounced fluorescence response at low pH. 
Next, we produced pH-sensitive chemical sensors for neurotransmitters. The 
sensors are designed to produce a turn-on fluorescence response upon exocytosis. 
Secretion from the acidic vesicle into the neutral synaptic cleft deprotonates the sensor 
and makes it highly fluorescent. The sensor’s fluorescence response is easily tuned by 
altering the pKa of the pH-sensitive group through a single coupling reaction.   
By slightly altering the coumarin core, we then achieved a three-input sensor for 
pH, glutamate, and zinc as the latter two molecules are copackaged in high 
concentrations in glutamatergic boutons. An 11-fold fluorescence enhancement of the 
sensor-glutamate-zinc bound complex was observed at the pH values germane to 
exocytosis. 
 
1 
 
CHAPTER ONE 
Introduction 
 
 
 
1.1 Fluorescence Sensing 
1.1.1 Molecular Recognition 
Molecular recognition is a wide field that involves the interaction of a host 
molecule with a guest through a reversible interaction which may include hydrogen 
bonding, dipole-dipole interactions, van der Waals forces, metal coordination, 
hydrophobic interactions, electrostatic effects, or covalent bonding.
1
 The host 
posseses an optical reporter and a recognition unit that associates with the analyte 
(Figure 1-1). 
 
 
Figure 1-1. Reversible host-guest interaction 
 
 The label “chemodosimeter” or “probe” is used if the equilibrium constant 
between the host and guest is strong enough to be irreversible.
2
 However, for 
continuous monitoring, a reversible “chemosensor” is desired which exhibits a 
binding constant comparable to the dissociation constant of the host-guest complex.  
 Equation 1 depicts the reversible binding of a host with a guest. Because the 
interaction between host and guest is reversible, there exists an equilibrium between 
2 
 
the unbound and bound species. The stronger the binding between the host and guest, 
the higher the equilibrium constant, also known as the binding or association constant 
(Ka) (eq. 2).  
  
   (eq. 1) 
 
         (eq. 2) 
 
 The projects described herein use covalent bonding interactions for analyte 
detection. There are many known reversible covalent interactions that are commonly 
employed for analyte recognition. Our research has largely exploited the reversible 
reaction between aldehydes and primary amines to form iminium ions (Figure 1-2, f). 
Later, we will discuss how covalent bond formation can alter the optical response of 
the host. 
 
 
Figure 1-2. Covalent analyte recognition motifs
2 
 
3 
 
1.1.2 Fluorescence Basics 
 Luminescence, or the emission of light from a substance, includes both 
phosphorescence and fluorescence phenomena.
3
 Phosphorescence is the process by 
which an electron is excited into a higher energy level, undergoes intersystem 
crossing (ISC), and relaxes from the triplet state (Figure 1-3). The emission process 
may take 10
-3
-10
2
 seconds. Fluorescence, on the other hand, is the direct relaxation of 
an excited electron to its ground state and subsequent emission of a photon which 
occurs on a much faster nanosecond timescale. Fluorescence is an incredibly sensitive 
technique that has harnessed interest in the fields of biology, pharmaceutics, and 
medicine for the purpose of investigating processes in living systems.
4
    
 
 
Figure 1-3. (a) Jablonski diagram and (b) photophysical timescales 
  
After a fluorophore is excited at a given wavelength, the electron relaxes, 
emitting a photon at a longer and lower energy wavelength. The difference between 
the absorption maxima and the emission maxima of the fluorophore is called the 
Stokes shift (Figure 1-4). This loss in energy can be attributed to: (1) the rapid decay 
of the electron to the lowest vibrational energy level of the S1 excited state; (2) the 
4 
 
thermalization of the excess vibrational energy; or (3) other effects due to excited 
state complex formation, solvent, or energy transfers.
3
 The shape of the absorbance 
and emission curves are almost always mirror images of each other as the absorption 
transitions from S0  S1 are generally the same for the emission and because S0 and 
S1 have similar vibrational energy levels. 
 
 
Figure 1-4. Stokes shift 
 
There are several environmental factors that affect the fluorescence of a fluorophore 
including solvent, temperature, viscosity, and pH. The influences of pH will be 
discussed further in Chapters 3 & 4. 
Fluorophores can be intrinsic (naturally fluorescent molecules) or extrinsic 
(synthetic molecules) in nature. Intrinsic fluorophores include proteins containing 
aromatic amino acids, hemoglobin, NADH, collagen, flavins, etc.
3, 5
 Many extrinsic 
fluorophores have also been developed and are useful tools in biological imaging and 
chemical sensing (Figure 1-5). Their fluorescence properties can be altered with 
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organic synthesis and functionalization with recognition handles permits interaction 
with various functional groups found on bioanalytes. 
 
 
Figure 1-5. Common extrinsic fluorophores in chemical sensing 
 
1.1.3 Mechanisms of Fluorescence Modulation 
 There are several signal transduction mechanisms by which fluorescence 
phenomena can be exploited for the purposes of bioimaging and sensing. This 
synopsis will include Förster resonance energy transfer (FRET), photoinduced 
electron transfer (PET), and internal charge transfer (ICT).  
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FRET 
FRET requires the presence of two tethered fluorophores: a donor and an 
acceptor.
6
 The emission spectrum of the donor chromophore must have sufficient 
overlap with the acceptor absorbance spectrum (Figure 1-6). The donor is excited 
with a laser and because its fluorescence emission band overlaps with the acceptor’s 
absorbance band, the acceptor is excited and emits at a longer wavelength. This 
phenomenon depends on the distance between the donor-acceptor pair. The distance 
at which the resonance energy transfer is 50% efficient is called the Förster distance 
and generally ranges from 20-60 Ǻ.3 
 
 
 
 
 
Figure 1-6. Spectral overlap of donor (D) and acceptor (A) FRET pairs 
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 FRET pairs have been used extensively in biology for studying conformational 
changes in proteins,
7
 visualizing gene expression,
8
 investigating protein activation.
9
 
and monitoring cellular levels of calcium,
10
 mercury,
11
 and thiols.
12
 This method has 
benefits in providing a ratiometric response allowing for analyte quantification.
13
 
However, FRET sensors sometimes suffer from formation of nonfluorescent dimers 
when the hydrophobic fluorophores stack on top of each other and poor cellular 
uptake due to the large size of many FRET complexes.   
 One recent example of a FRET sensor for bioanalytes comes from the Hamachi 
lab and is for the turn-on fluorescent detection of nucleoside polyphosphates (Figure 
1-7).
14
 Prior to phosphate addition, only blue fluorescence is exhibited by the 
coumarin fluorophore. The unconjugated xanthene absorbs at very low wavelengths. 
However, the addition of nucleotide polyphosphates promotes elimination of the zinc-
bound water to yield the fully-conjugated fluorescein product whose absorbance has 
good overlap with the coumarin emission. Upon excitation, FRET occurs and green 
emission from the fluorescein is visualized. This sensor was used to monitor 
enzymatic reactions in vitro such as saccharide synthesis and phosphorylation that 
involve nucleoside polyphosphates as substrates, which further substantiates small 
molecular systems as simple yet powerful tools for monitoring biological processes.
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Figure 1-7. A molecular sensor that uses a turn-on FRET response for the 
visualization of nucleoside polyphosphates 
 
PET 
 PET quenching occurs when the excited electron of a fluorophore is unable to 
relax and emit a photon (fluoresce) due to the presence of a nearby electron-donating 
or –accepting species.3 There are two forms of PET quenching (Figure 1-8). 
Acceptor-excited PET occurs when the fluorophore (acceptor) is excited and an 
electron from the quencher (donor) fills the ground state of the acceptor.
15
 
Fluorescence is prohibited and the excited electron must relax via some non-radiative 
process. Donor-excited PET occurs when the fluorophore (donor) is excited and 
instead of relaxing to emit a photon, the excited electron transfers into the LUMO of a 
nearby quencher (acceptor). PET sensors have been employed for the intracellular 
measurement of pH
16,17
 and for many bioanalytes such as nitric oxide,
18
 mercury,
19
 
copper,
20
 zinc,
21,22 
and thiols.
23,24
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Figure 1-8. Acceptor- and donor-excited PET quenching 
 
 Here is a recent chemosensor developed for the aqueous detection of mercury 
uses a turn-off acceptor-excited PET mechanism (Figure 1-9).
19
 The addition of 
mercury promotes desulfurization and the formation of a 1,3,4-oxadiazole derivative. 
Removal of the thiocarbonyl group increases the electron density of the aniline which 
can then donate an electron to the fluorophore and quench fluorescence. 
 
 
Figure 1-9. Molecular sensor for mercury that uses an acceptor-excited PET 
mechanism. 
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ICT 
 A fluorophore can form an ICT state if it contains both an electron-donating 
group (EDG) and an electron-withdrawing group (EWG).
3
 The two substituents are in 
conjugation with each other and are separated by the extended π-system. Excitation 
can increase the charge transfer across the fluorophore and this charge separation may 
become the lowest energy state, especially if stabilized by a polar solvent. 
Fluorophores exhibiting these characteristics often produce a bathochromic shift with 
stronger electron donor-acceptor pairs (Figure 1-10).
25 
 
 
Figure 1-10. The effect of EDGs and EWGs on the absorption of several 2,5-
diphenyloxazole (DPO) derivatives.
25
  
  
Shown below is a representative example of a chemosensor that uses an ICT 
mechanism and uses a BODIPY core with extended conjugation  (Figure 1-11). 
26
 
When no metal is present, the tertiary nitrogen from the dipicolylamine (DPA) 
donates its lone pair into the pi-system of the fluorophore leading to a strong ICT 
state. Upon the addition of cadmium, the metal coordinates with all three nitrogens of 
11 
 
the DPA which reduces the ICT across the fluorophore and results in a blue-shifted 
emission. 
 
 
Figure 1-11. BODIPY-based chemosensor that detects cadmium through the 
reduction in the ICT state. 
 
1.2 Detection of Amino Acids 
Amines are ubiquitous in biology and are important components to amino acids, the 
subunits of proteins, and key neurotransmitters such as dopamine, norepinephrine, 
epinephrine, and serotonin. Amino acids play a multitude of roles in physiological 
processes including protein and enzyme synthesis, metabolic pathway regulation, 
hormone production, muscular structure, and neurotransmission.
27,28
 Due to their 
biological importance, the development of optical probes for their facile and continuous 
detection has garnered much interest in recent years. Fluorescent and colorimetric 
chemosensors have detected AAs is through indicator displacement assays 
(IDA),
29,30,31,32,33 
hydrogen-bonding,
34,35,36,37,38
 covalent cleavage of fluorescence 
quenchers,
39,40
 metal ion coordination,
41
 Michael additions,
42,43,44
 thiazinane and 
thiazolidine formation,
39,40
 and imine formation.
45,46,47,48
 Only a select few of these are 
highlighted below (Figure 1-12). 
12 
 
 
Figure 1-12. Examples of amino acid detection using metal coordination, covalent 
interactions, and hydrogen bonding 
41, 49
 
 
Our research group has focused on the reversible formation of iminium ions due to 
the covalent bonding between aldehydes and amines. In 2003, the group published 
compound 1, the first chemosensor for amino acids where a turn-on fluorescence 
response was noted due to the formation of an iminium ion in high salt aqueous 
conditions (Figure 1-13).
48
 Binding of the sensor to the amino acid induced a 
bathochromic shift of 34 nm and by exciting the bound complex at 495 nm, a 
fluorescence increase to analyte addition was noted (Figure 1-14).  
 
 
13 
 
 
Figure 1-13. Reversible covalent interaction of a coumarin aldehyde to an amino acid 
 
 
Figure 1-14. (a) UV/Vis and (b) fluorescence spectra of sensor 1 (10 M) adding 
aliquots of glycine in buffer (100 mM NaCl, 50 mM HEPES, pH 7.4, 37 °C). ex = 495 
nm.
48 
 
The sensor was then examined with a variety of analytes (Table 1-1). The sensor was 
selective for amino acids and did not bind to secondary amines or hydroxyacids. All 
amino acids gave single-digit binding constants with the butylated diethylaminocoumarin 
aldehyde, the highest tested being lysine (6.5 M
-1
). Fluorescence enhancements to analyte 
addition, on the other hand, were very impressive and ranged between 23- and 45-fold.  
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Table 1-1. Equilibrium constants (Keq) and fluorescence 
enhancements of sensor 1 with various analytes.
a
 
Analyte Keq (M
-1
) Imax/I0
b
 
glycine 4.0 26 
aspartate 2.3 40 
glutamate 2.4 45 
lysine 6.5 29 
serine 5.2 23 
,8-alanine 2.5 23 
alanine 1.4 29 
ethanolamine 6.7 15 
1,3-diamino-propane 12.5 22 
lactic acid - - 
diethylamine - - 
a
Measured by fluorescent titration of 1 with amines at 37 °C; ex = 495 
nm; 100 mM NaCl; 50 mM HEPES; pH 7.4. 
b
Imax is the maximum 
intensity at saturation taken from the fit of the titration data. 
 
1.3 Detection of Neurotransmitters 
Neurotransmitters are a very important class of biomolecules as they regulate 
numerous behavioral and cellular processes. These chemicals are taken up into vesicles 
using either an electrochemical gradient or a proton pump (Figure 1-15).
50
 In the latter 
case, protons are exchanged for neurotransmitters using a neurotransmitter transporter 
until a very high concentration has accumulated within the vesicle (0.2-1.0 M).
51,52,53,54
 
An excess of protons also leaves the vesicle acidic at ~pH 5.
55,56
 These two 
characteristics will be very important to understanding the function of our sensors. Many 
neurotransmitters possess amine functional groups, that can serve as a handle for 
molecular recognition (Figure 1-16). 
 
15 
 
 
Figure 1-15. Neurotransmitter (NT) uptake into synaptic vesicles. A proton pump uses 
the hydrolysis of ATP to pump protons into the vesicle. The vesicular monoamine 
transporter (VMAT) exchanges protons for neurotransmitters. The end result is an acidic 
vesicle (pH ~5) that is highly concentrated with neurotransmitters (0.3-1.0 M). 
 
 
Figure 1-16. Molecular structures of select amine neurotransmitters 
 
Scientists have many tools with which to study the brain, however, there are a 
limited number of strategies that will detect the neurotransmitter itself. Indirect 
techniques that do not specifically detect neurotransmitters, but do provide information 
regarding brain structure and function include heavy metal staining (uranium, lead, 
osmium) followed by electron microscopy,
57,58
 immunofluorescence,
59,60
 membrane 
16 
 
probes (FM dyes, 
61
 pHluorins
62
), and fluorescent tracers (FFNs).
63
 On the other hand, 
techniques for direct detection of neurotransmitters including separation/analysis methods 
(HPLC-MS,
64
 CE-LIF
65
), electrochemistry (cyclic voltammetry,
66
 amperometry
67,68
), 
biosensors,
69
 and small chemical sensors.
70,71
  
The standard method for detecting neurotransmitters has been through 
electrochemical processes (Figure 1-17).
72
 Catecholamines are easily oxidized to 
quinones which can be detected by an electrode. However, in order to achieve spatial 
resolution and/or monitor multiple vesicles at once, we have chosen to use fluorescent 
sensors which will be described in more detail. 
 
 
Figure 1-17. Detection of dopamine through an electrode using cyclic voltammetry.
72
 
Potential is applied to an electrode, dopamine becomes oxidized to the quinone, and the 
two lost electrons are detected as current which is proportional to the number of 
molecules electrolyzed. 
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Biosensors 
 Biosensors have been a popular method used to monitor exocytosis by directly 
binding to the neurotransmitters typically using neurotransmitter-specific binding 
proteins. Tsien and colleagues have developed several FRET-based tools for glutamate 
imaging including glutmate-sensing fluorescent reporters (GluSnFRs & SuperGluSnFRs) 
and fluorescent indicator proteins for glutamate (FLIPEs) (Figure 1-18).
73,74,69a
 For 
SuperGluSnFRs, the surface of hippocampal neurons were linearly fused with glutamate 
periplasmic binding protein (GltI), cyan fluorescent protein (CFP) and yellow fluorescent 
protein (YFP). When glutamate is bound to GltI, there is a change in the distance 
between the two fluorescent proteins and consequently the FRET. In in vitro studies, the 
sensor displayed a 44% change in FRET emission ratio upon glutamate binding (Ka = 
400,000 M
-1
).
69a
  
 
 
Figure 1-18. Graphic of surface-displaced GluSnFR in a ligand-free state 
 
 Researchers from the Johnsson group have developed FRET-based probes for 
both glutamate and GABA.
69b, 69c
 The semisynthetic fluorescent sensor proteins (Snifits) 
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are fused to the extracellular surface of the cell and contain a SNAP-tag, CLIP-tag, and a 
protein that binds to the specific analyte (Figure 1-19). The semisynthetic glutamate 
sensor (Snifit-iGluR5) was used to label the outer membrane of human embryonic cells 
(HEK 293) in hopes of monitoring only secreted glutamate. When glutamate is present, it 
displaces a bound antagonist and changes the FRET ratio. A binding constant of Ka = 
67,000 M
-1
 was obtained for glutamate. This biosensor had a better ratiometric change 
than previously discussed sensor by Tsien (156% vs. 44%). 
 
 
Figure 1-19. Snifit sensor for sensing glutamate. The glutamate analog (gray ball) is 
bound to the receptor (iGluR5) and FRET occurs between the two fluorophores (stars). 
The addition of glutamate (pink ball) displaces the intramolecular ligand which separates 
the fluorophores so that no FRET occurs. 
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Chemical Sensors 
 
 
Figure 1-20. Examples of chemical sensors for neurotransmitters (dopamine and GABA 
shown). 
 
Only a few chemical sensors for the direct detection of neurotransmitters have 
been developed (Figure 1-20). 
70b,71,48, 70a
 The key challenges in developing such sensors 
include achieving water-solubility, using the recognition motifs of electrostatic 
interactions and hydrogen bonding in water, and overcoming the strong fluorescence 
quenching properties of catecholamine and indoleamine neurotransmitters. Aromatic 
neurotransmitters tend to quench fluorescence as they are easily oxidized and can donate 
an electron into the ground state of the excited fluorophore leading to acceptor-excited 
PET quenching (Figure 1-21). 
 
 
Figure 1-21. Quenching ability of aromatic neurotransmitters 
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Our group has developed a series of sensors for the detection of primary amine 
neurotransmitters (Figure 1-22).
46, 70a
 The first generation sensor was intended to bind to 
catecholamine neurotransmitters with high affinity. It bound to dopamine with an affinity 
of 3400 M
-1
 due to a strong two-point binding interaction but gave a turn-off fluorescence 
response due to quenching from the analyte catechol. The second generation sensor was 
designed to give a turn-on response due to fluorescence-modulating effects of an added 
p-methoxyphenyl substituent. The one-point binding strategy resulted in lower binding 
affinities to the neurotransmitters but to no adverse effect in practical applications as will 
be explained in later chapters.   
 
 
Figure 1-22. First- and second-generation catecholamine sensors based on the coumarin 
aldehyde scaffold shown bound to dopamine. 
 
1.4 Monitoring Exocytosis 
 While the static imaging of neurotransmitters is important, researchers would also 
like to monitor exocytosis and the detailed mechanics behind neurotransmission. Several 
methods have been developed to do so, namely, through the use of FM dyes, 
synaptopHluorins, and fluorescent false neurotransmitters (FFNs).
75
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1.4.1 FM Dyes 
 FM dyes are amphiphilic styryl pyridinium molecules that have been used 
to monitor exocytosis (Figure 1-23).
76,61a, 61b
 The dye has a charged polar head and 
a lipophilic tail. The fluorescence is environment-dependent and only turns on 
when the lipophilic tail inserts into a hydrophobic medium, such as a lipid 
membrane. In neuroscience, the dye is added to the extracellular space 
surrounding neurons. Stimulation is applied which causes the vesicles to release 
neurotransmitters and upon subsequent endocytosis, the dye is taken up and 
inserts into the intravesicular membrane. All remaining dye is washed away, and 
the vesicles can be clearly visualized. Exocytosis is monitored as a measure of 
fluorescence decrease. After the dye has been internalized, the cell can be 
stimulated again, the dye is released and dispersed, and the fluorescence signal 
disappears. 
  
 
Figure 1-23. Structure and mechanism of FM dyes. (a) Molecular structure of FM 1-
43, and (b) FM dye uptake into the axonal terminus of a neuron: 1) An action 
potential stimulates exocytosis of the vesicle. Neurotransmitters (NTs) are released. 
2) Dye from the extracellular space is taken up into the vesicle upon endocytosis. 3) 
The dye partially inserts into the hydrophobic intravesicular membrane which causes 
a fluorescence increase. 
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1.4.2 SynaptopHluorins 
 pH-sensitive proteins called “pHluorins” were developed to respond to the 
difference in pH between the synaptic vesicle (pH ~5) and the synaptic cleft 
(pH~7.4). 
62b, 77,78,62a,79
 The pHluorins are fused to the intravesicular membrane 
and have been genetically-engineered to incorporate green fluorescent protein 
(GFP) mutant which has had key residues replaced with pH-sensitive amino acids 
(Figure 1-24). The mutant is fluorescent at pH > 6 but not in more acidic media.  
 
 151    200 
GFP2 YIMADKQKNG IKVNFKIRHN IEDGSVQLAD HYQQNTPIGD GPVLLPDNHY 
pHluorin YIMADKQKNG TKAIFQVHHN IEDGGVQLAD HYQQNTPIGD GPVLLPDNHY 
      
 201   239  
GFP2 LSTQSALSKD PNEKRDHMVL LEFVTAAGIT LGMDELYK*  
pHluorin LHTQSALSKD PNEKRDHMVL LEFVTAAGIT HGMDELYK*  
Figure 1-24. Segment of the amino acid sequences for GFP and pHluorin with key 
differences highlighted.
80
 
 
The GFP mutant is fused to the luminal vesicular membrane and has low 
fluorescence when the vesicle is closed due to being protonated in the acidic 
environment. However, when the vesicle docks and undergoes exocytosis, the 
pHluorins are exposed to the pH 7.4 cytosol which causes deprotonation and a 
fluorescence turn-on response. 
 Ratiometric pHluorins have been used to measure intravesicular pH as 
well as to identify a readily releasable pool of vesicles in the axonal terminal.
79
 
FM dyes and synaptopHluorins have been used in concert to study localization of 
both endocytosis and exocytosis. Such studies have found that that fluorescence 
signals from the two dyes colocalize when stimulated with high frequency, though 
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the events of exo- and endocytosis appear to occur on different time scales.
81
 The 
researchers concluded that the exocytotic pathway (visualized with 
synaptopHluorins) and the endocytotic pathway (visualized with FM dyes) are 
important to the synaptic vesicle cycle when stimulated at high frequencies. 
 
1.4.3 False Fluorescent Neurotransmitters (FFNs) 
 Fluorescent false neurotransmitters (FFNs) have been developed as 
neurotransmitter mimics to help monitor vesicular events (Figure 1-25).
63, 82
 Their 
structure includes a coumarin fluorophore with a donor group at the 7-position 
and an ethylamine moiety at either the 3- or 4-positions. FFNs are taken up into 
synaptic vesicles via the VMAT2 monoamine transporter protein and give 
punctate fluorescence as they are copackaged with neurotransmitters in high 
concentration within secretory vesicles. 
 
 
Figure 1-25. Structures of FFN dyes 
 
The pH-sensitive versions of FFNs have hydroxyl donors at the 7-position that 
can become deprotonated upon exocytosis. Chlorines were appended and the 6-
position of the ethylamine moiety altered to modify the pKa value of the hydroxyl 
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proton. These FFNs can monitor pH within the vesicle and are shown to increase 
the background fluorescence within mouse brain striatal slices upon addition of 
amphetamine, addition of high K
+
, or electrical stimulation. 
  
 
Figure 1-26. Summary of indirect methods to monitor neurotransmitter uptake and 
release. Yellow and blue circles are fluorescent and nonfluorescent dyes, respectively. 
Black dots are neurotransmitters. FM dyes fluoresce only after being taken up into the 
synaptic vesicle upon endocytosis and embedding in the intravesicular membrane. 
SynaptopHluorins, become deprotonated and fluoresce when exposed to the cytosol upon 
exocytosis. FFNs are neurotransmitter mimics and show punctate fluorescence when 
accumulated within vesicles alongside neurotransmitters. 
 
The aforementioned methods consist of probes that monitor the event of 
exocytosis, but do not monitor the neurotransmitters, themselves, and may require 
laborious genetic modification of the vesicle (Figure 1-26). There are as of now, 
no molecular sensors that directly bind to and visualize the release of 
neurotransmitters in live cells. We will describe in Chapters 3 and 4 the 
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development of chemosensors for the direct detection of neurotransmitter release 
from secretory vesicles. 
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CHAPTER TWO 
A Fluorescent Sensor for Kynurenine 
 
 
 
2.1 Overview 
 Kynurenine, a metabolite of tryptophan, is a precursor to the biological 
production of picolinic acid and NAD (Figure 2-1).
83
 Abnormally high concentrations 
have been associated with coronary heart disease, invasive tumor growth, Huntington’s, 
Alzheimer’s, and other neurological diseases. 84,85,86 Kynurenine acts as an endogenous 
ligand for the aryl hydrocarbon receptor (AHR) that inhibits antitumor immunological 
responses by suppressing allogenic T-cell proliferation.  As a result, elevated levels of 
kynurenine allow for unhindered invasive tumor growth.
87,88
 As the first stable 
intermediate in the kynurenine pathway, kynurenine is generated when the indoleamine 
2,3-dioxygenase (IDO) or tryptophan dioxygenase (TDO) enzymes are activated. The 
ratio of kynurenine to tryptophan is often used as an index of IDO and TDO activity.  
Both increased IDO/TDO activity and high AHR levels have been correlated with poor 
prognosis in cancer patients further tying kynurenine and its known functions to cancer 
progression. 
The selective detection of kynurenine is material in the ongoing study of cancer 
progression. Current detection methods include HPLC,GCMS, biosensors, and various 
electrochemical techniques that entail costly or time-consuming preparations.
89,90,91,92,93
 
Fluorescent sensors, by contrast represent a convenient and sensitive method for analyte 
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detection. We sought to develop a fluorescent sensor for kynurenine by binding to its 
primary amine functional groups. 
 
 
Figure 2-1. The kynurenine pathway 
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Our group has previously demonstrated that coumarin aldehydes reversibly bind 
to primary amines which induces a bathochromic shift in absorbance (Figure 2-2).
48
 
Sensor 1 functions through an internal charge transfer (ICT) mechanism whereby the 
tertiary nitrogen serves as the electron donor and the aldehyde acts as the electron 
acceptor. The aldehyde of the sensor reversibly binds to primary amines to form a 
positively charged iminium ion that enhances the ICT and modulates both the absorbance 
and fluorescence. The red shift in absorption upon analyte binding permits excitation and 
monitoring of the sensor in both its unbound and bound states. 
 
 
 
Figure 2-2. Binding of glycine to sensor 1 induces a bathochromic shift in absorbance 
 
2.2 Coumarin Dimers 
 Kynurenine is unusual in that it possesses both an aliphatic and an aromatic 
primary amine, and until now we had not examined the interaction of aromatic amines 
with our sensor system. Therefore, coumarin aldehyde dimers were developed for two-
point binding which would theoretically increase the sensitivity of the sensor to 
kynurenine. Two dimers with varying linker lengths were designed with the hope that one 
would better assume the geometry necessary for two-point binding with kynurenine.  
Dimers 7 and 8 were synthesized from the commercially available 7-
diethylamino-4-hydroxycoumairn core (2) by first doing an in situ tosylation and Suzuki 
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coupling reaction to afford compound 3 (Figure 2-3). Demethylation using BBr3 was 
followed by dimerization using potassium carbonate and dibromoalkanes. Subsequent 
formylation rendered the final sensors 7 and 8. 
 
 
Figure 2-3. Synthesis of oxygen-linked coumarin dimers for kynurenine detection 
 
 It was noted that 7 and 8 were not water soluble likely due to the planarity of the 
molecules’ aromatic rings as well as the hydrophobicity of the alkyl linker. Therefore, to 
achieve higher water solubility we designed amine-based linkers that would be 
protonated in solution (Figure 2-4). However, the last dimerization step would only return 
starting material. 
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Figure 2-4. Synthesis of amine-linked coumarin aldehyde dimers for kynurenine 
detection 
 
 
2.3 Coumarin Monomer 
 Due to difficulties with synthesis and solubility of the coumarin dimers, the 
coumarin monomer model was pursued (Figure 2-5). We functionalized the coumarin 
core with alkyl thiols in a similar fashion to previously reported quinolone aldehydes.
47
 
 
 
Figure 2-5. Synthesis of coumarin aldehyde monomer for kynurenine detection 
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 Initial efforts to test sensor binding to kynurenine were hampered by its low 
solubility in neutral aqueous media. Therefore, the solution pH was lowered to 1.0 to 
enhance kynurenine solubility and the absorbance and fluorescence spectra were 
monitored (Figure 2-6). Sensor 14 has an absorption band at 468 nm. This wavelength of 
absorption is typical for the coumarin aldehydes and indicates that the diethylamino 
donor group is not protonated even at this low pH. Upon the addition of kynurenine, two 
new absorption bands were observed at 525 and 555 nm at pH 1. This represents an 
unprecedented bathochromic shift of 87 nm compared to the ~35 nm shift that is typical 
for the coumarin aldehyde class of sensors.
48
  
 
 
Figure 2-6. (a) UV/vis and (b) fluorescence spectra (λex = 555 nm) of sensor 14 (10 μM) 
in buffer (50mM H3PO4, 120 mM NaCl, pH 1, 1% DMSO) adding aliquots of 50 mM 
kynurenine. Inset is the fit to a one-site binding isotherm. 
 
The fluorescence emission spectrum mirrors the absorbance spectrum revealing 
two bands at 586 and 632 nm upon excitation at 555 nm. Because sensor 14 does not 
absorb above 530 nm in its unbound form, exciting at 555 nm realizes the fluorescence 
emission from the bound sensor only. Binding to kynurenine provides a pronounced 390-
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fold fluorescence enhancement. Furthermore, the binding constant with kynurenine was 
1880 M
-1
, which is nearly three orders of magnitude higher than the binding of an 
aliphatic primary amine to the coumarin aldehyde sensors.
48 
We surmised that the aromatic amine must be involved in extending the 
conjugation of the chromophore. To test this hypothesis, we titrated sensor 14 with 
aniline which gave a similar, though smaller, bathochromic shift with two distinct bands 
(Figure 2-7). The larger shift and higher binding constant of kynurenine is attributed to 
the ortho-carbonyl group, which extends the conjugation of the chromophore with an 
additional electron-withdrawing group. 
 
 
Figure 2-7. UV/vis spectrum of sensor 14 (10 μM) with various analytes (5 mM 
kynurenine; 16 mM aniline; 360 mM glycine) in buffer (50 mM H3PO4, 120 mM NaCl, 
pH 1, 1% DMSO). 
 
A pH titration of the sensor-kynurenine bound complex gave a pKa of 2.5 that is 
consistent with the pKa of an aniline Schiff base (Figure 2-8).
94
 Upon raising the pH of 
the solution, the long wavelength absorption is lost. The sensor response requires that the 
imine be protonated, thus the sensor only operates at low pH. It should be noted that a 
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Schiff base from an aliphatic amine has pKa values of ∼6-8.
95
 This supports the notion 
that it is the aromatic amine of kynurenine that binds to the sensor. 
 
 
Figure 2-8. (a) UV-vis spectra and (b) binding isotherm of the pH titration of the 14 -
kynurenine complex with 4 M NaOH. The sensor (10 μM) was saturated with kynurenine 
(8 mM) and the absorbance at 555 nm monitored over a pH range (0.9-5.6). A pKa of 2.5 
was obtained from the best-fit curve. 
 
 To test for selectivity, sensor 14 was titrated with other biological amines and the 
fluorescence was monitored. The various analytes bound to sensor 14 weakly and 
provided only modest bathochromic shifts. In turn, no fluorescence response was 
observed when excited at 555 nm (Table 2-1).  Even aromatic primary amines such as 
adenosine provided no response.  Thus, sensor 14 is highly selective for kynurenine. 
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Table 2-1. Association constants and spectroscopic results from the binding 
of sensor 14 (10 M) with various bioanalytes (50-500 mM) 
Analyte Ka (M
-1
)
a 
max1 (nm) max2 (nm) Isat/I0
b 
 
 
kynurenine 
1880
 
525 555 390 
 
 
glycine 
8.0 483 507 n.d. 
 
adenosine 
5.3 470 - n.d. 
 
cytidine 
1.6 470 - n.d. 
 
 
aniline 
600 510 536 220 
a
Error in Ka is  5% based on triplicate titrations;
b
 ex = 555 nm; n.d. = not determinable 
 
A competitive binding study was performed to investigate the effect of competing 
analytes on the binding of sensor 14 to kynurenine (Figure 2-9).  Sensor 14, kynurenine 
(10 mM), and various competing analytes (100 mM) were combined and the fluorescence 
intensities observed with an excitation of 555 nm. The relative fluorescence intensity did 
not change when competing analytes were added in 10-fold excess.  These data indicate 
that sensor 14 can selectively sense kynurenine in complex mixtures containing other 
biological aromatic and aliphatic primary amines.  
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Figure 2-9. Fluorescence emissions of sensor 14 (10 μM) at em = 586 nm with 
kynurenine (10 mM) in the presence of various analytes (100 mM) in buffer (50 mM 
H3PO4, 120 mM NaCl, pH 1, 1% DMSO). 
 
In conclusion, we have developed sensor 14 as a tool for the selective detection of 
kynurenine.  The coumarin aldehyde confers a turn-on fluorescence response upon 
binding due to an enhanced charge transfer.  This method is unique in that kynurenine is 
incorporated as part of the fluorophore thus giving exquisite selectivity for the target 
analyte due to an unprecedented bathochromic shift.  Other biological amines form bound 
complexes that do not absorb at such high wavelengths.  The considerable fluorescence 
enhancement seen upon binding to kynurenine is unperturbed by the presence of excess 
competing analytes and further substantiates sensor 14 as a means to monitor kynurenine 
in order to facilitate studies of cancer initiation and progression. 
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CHAPTER THREE 
Visualizing Exocytosis with Sulfonamide Coumarins 
 
 
 
3.1 Background 
Neurotransmitters are critical to the regulation of the central and peripheral 
nervous systems and command a number of functions such as learning, memory, sleep, 
and movement.
96,65
 Discerning the machinery involved in vesicular fusion, the 
spatiotemporal mechanisms of synaptic release, and the chemical activity of 
neurotransmitters is vital to understanding both normal and atypical cellular processes. 
The ability to effectively monitor exocytotic operations bolsters research in neuroscience, 
serving as a useful tool in the study of neurophysiology and neuropsychiatric disorders. 
Methods to evaluate exocytosis include fluorescence imaging,
79,63a,97,98,99
 capillary 
electrophoresis,
100,101,102,103
 microelectrochemistry,
104,105
 and mass spectrometry
106
. Non-
optical techniques are limited by poor throughput and a lack of spatial resolution.
107
 
Conversely, fluorescence methods offer a sensitive means to elucidate the spatial 
distribution of neuronal vesicles and chemical messengers.   
Fluorescence imaging of secretion was studied early on by loading chromaffin 
cells with acridine orange and observing a loss in fluorescence upon exocytosis.
99
 More 
recently, exocytosis has been visualized using the genetically-encoded synapto-
pHluorins, wherein a pH-sensitive GFP construct is expressed on the inner membrane of 
secretory vesicles.
79
 The engineered vesicles fluoresce upon exocytosis due to a change 
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in pH from the acidic synaptic vesicle (~5) to the neutral synaptic cleft (~7.4). These 
methods solely monitor the process of vesicle membrane fusion during an exocytotic 
event but do not directly image active neurotransmitters released upon exocytosis. In 
recent years, a genetically-encoded CFP/YFP FRET biosensor was developed to monitor 
glutamate release, spillover, and reuptake by fluorescence.
69a
 However, these protein-
based biosensors require genetic manipulation and display high, irreversible affinity for 
glutamate with limited dynamic range and overall small changes in fluorescence. To 
avoid the use of protein-based fluorophores, a pH sensitive fluorescent false 
neurotransmitter (FFN) has been developed to monitor exocytosis. This fluorescent tracer 
is loaded into vesicles expressing VMAT and fluoresces upon exocytosis similar to the 
synapto-pHluorins.
63c
 We wanted to develop a direct method of visualizing 
neurotransmitter exocytosis that would not interfere with native cell behavior and so we 
turned to fluorescent molecular logic gates. 
 
3.2 Molecular Logic Gates 
A molecular logic gate represents a chemical system with two or more semi-stable 
states that possess distinct chemical or physical properties and can be reversibly 
interconverted.
108
 The device has one or more inputs that provide a logical output 
depending on their presence (“1”) or absence (“0”). Fluorescent chemical sensors can be 
considered a type of logic gate as the presence of an analyte (input) can either switch the 
fluorescence (output) on or off. When analyte addition switches the fluorescence on, the 
sensor is termed a “YES” logic gate. If the fluorescence turns off, it is termed a “NOT” 
logic gate.
109
 Depending on the number of inputs, a host of logic functions may exist 
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including YES, NOT, AND, OR, NOR, NAND, INHIBIT, and XOR (Figure 3-1).
110
 The 
number of potential outputs and overall complexity of the system grows exponentially 
with increasing inputs. 
 
 
Figure 3-1. Symbols and truth tables for several logic operations 
 
3.3 NeuroSensors 
 Our group has developed a series of molecular logic gates for neurotransmitters 
that rely on one, two, or three inputs. The first sensors in the series are single-input YES 
logic gates called “NeuroSensors.”46 NeuroSensors are designed to image 
neurotransmitters within vesicles and only rely on the presence of the neurotransmitter to 
provide a fluorescence response (Figure 3-2). They consist of a coumarin scaffold with an 
electron-donating group at the 7-position, an aryl group at the 4-position to modify the 
fluorescence response, and the analyte-sensitive aldehyde at the 3-position. As discussed 
in Chapter 1, the sensors fluoresce through an internal charge transfer (ICT) signal 
transduction mechanism. Upon neurotransmitter binding, the charge transfer increases 
which both red-shifts the absorption and increases the fluorescence response due to 
selective excitation at the longer absorption wavelength of the bound species. 
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Figure 3-2. Logic gate and truth table for NeuroSensors. The molecular logic gates 
fluoresce upon neurotransmitter (NT) binding. EDG = electron-donating group. Ar = aryl 
group. 
 
 The practical application of NeuroSensors was tested using NeuroSensor 521 in 
norepinephrine- and epinephrine-secreting chromaffin cells which serve as a standard 
model for monitoring neurotransmitter secretion.
46
 Upon incubation within the cells, 
punctate fluorescence was observed only when exciting at 488 nm, the sensor’s bound 
wavelength (as opposed to the unbound wavelength of 440 nm) and only with 
norepinephrine, a primary amine neurotransmitter (as opposed to epinephrine, a 
secondary amine). These results indicate that the sensor is only present in its bound state 
within norepinephrine-secreting vesicles where the neurotransmitter is highly 
concentrated (Figure 3-3).
54
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Figure 3-3. Confocal fluorescence microscopy of NeuroSensor 521 (0.1 µM) incubated 
with epinephrine- (a & c) and norepinephrine-secreting (b & d) chromaffin cells. 
Excitation at 488 nm (a & b) images the sensor in its bound state, while excitation at 440 
nm (c & d) images the sensor in its unbound state. Punctate fluorescence pattern is 
indicative of the sensor binding within secretory vesicles. 
 
 The noted accumulation within vesicles and selective binding can be explained 
using Figure 3-4. We hypothesize that the sensor diffuses into the vesicle in its neutral 
form, binds to norepinephrine, and becomes trapped because the positively-charged 
iminium ion formed upon binding cannot cross the vesicular membrane. Please note that 
this property of becoming trapped once bound is also an important feature for the 
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subsequent logic gates. The sensor cannot bind to epinephrine because it is a secondary 
amine. Therefore, it is free to diffuse back out of the vesicle in its neutral form and be 
washed away in pre-imaging cellular preparations. 
 
 
Figure 3-4. Pictoral representation of selective binding for NeuroSensor 521. 
NeuroSensor 521 (blue) can diffuse into the vesicle, bind to norepinephrine (NE) and 
become trapped due to the formation of a positively-charged bound complex. However, 
the sensor cannot bind to epinephrine (EP) and hence, diffuses out of the vesicle in its 
neutral unbound form. Epinephrine cells contain a specific enzyme (green triangle) that 
can be used to verify the selectivity of the sensor for norepinephrine over epinephrine 
cells using an immunofluorescence assay that tags only the EP cells with a Cy3 dye (pink 
ball). 
 
3.4 ExoSensors 
The second class of molecular logic gates that we developed are called 
“ExoSensors.” They were developed to monitor primary amine neurotransmitters only 
upon release from the secretory vesicle.  ExoSensors are two-input AND gates that 
produce a fluorescence response only upon neurotransmitter binding and the pH change 
associated with exocytosis (pH 5  7.4). They require both inputs to be present in order 
to produce a fluorescence output (Figure 3-5). The molecular logic gate design strategy 
allows for direct imaging of released neurotransmitters while minimizing interference 
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with native neurotransmitter trafficking due to the reversible recognition motif and small 
size of the sensor. 
 
 
      
Figure 3-5. Logic gate and truth table for ExoSensors. The molecular logic gates respond 
only upon concomitant neurotransmitter (NT) binding and the pH change associated with 
exocytosis.  pH = pH increases from 5 to 7.4. 
 
3.5 Design of ExoSensors 
We built our design using the NeuroSensor 521 model as it was shown to be 
effective at binding norepinephrine, a primary amine neurotransmitter, in live secretory 
cells (Figure 3-3).
46
 While the coumarin aldehyde could technically bind to any primary 
amine analyte present in the cell, “specialized” neurons (e.g., glutamatergic, 
dopaminergic, serotonergic, etc.) package only one specific neurotransmitter at very high 
concentrations, and would therefore be the only amine visualized, especially given the 
relatively weak binding constant. To image the exocytosis of these specially packaged 
neurotransmitters, we sought to create a pH-sensitive analog of NS521 that would have 
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weak fluorescence in the synaptic vesicle (pH 5) but strong fluorescence in the synaptic 
cleft (pH 7.4). 
As depicted in Figure 3-6, the dual-analyte sensor can enter the vesicle and 
selectively bind to the highly concentrated primary amine neurotransmitter, yet remain 
fluorescently “off” due to the acidic environment. Formation of a positively-charged 
complex causes the bound sensor to become trapped within the vesicle, encouraging 
sensor accumulation. Exocytosis releases the bound sensor complex into the synaptic 
cleft and the change in environmental pH switches the fluorescence “on” for only the 
released sensor in its bound state. 
It is imperative that the sensor enters the vesicle and binds to the neurotransmitter 
before release. The reason is that binding may take seconds to occur, whereas exocytosis 
occurs on a millisecond timescale.
111,112 
The sensor would not be able to keep up with 
synaptic firing. Our strategy allows the sensor to bind to the neurotransmitter and lay in 
wait until vesicular release. The turn-on fluorescence response is switched on by 
deprotonation of the bound complex which occurs on a much faster microsecond 
timescale.  
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Figure 3-6. Sensing mechanism of ExoSensors. a) Sensor enters vesicle and selectively 
labels the neurotransmitter (NT). The bound complex accumulates but fluorescence is 
“off” due to low pH (~5). b) Influx of Ca2+ triggers exocytosis. The increase in 
environmental pH in the synaptic cleft (7.4) switches the fluorescence “on.” 
 
To create a sensor that would respond in this way, the diethyl amino group of 
NS521 was exchanged for an electron-poor sulfonamide that can be deprotonated at 
neutral pH to become electron-rich (Figure 3-7). The sensor fluoresces via an 
intramolecular charge transfer (ICT) state in which the deprotonated sulfonamide acts as 
an electron donor and the iminium ion acts as an electron acceptor. Both analyte binding 
and sulfonamide deprotonation enhance the charge transfer across the fluorophore. In 
addition, both binding to the analyte and deprotonation of the sensor produce large 
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bathochromic shifts which means exciting at the highest possible wavelength of 
absorption permits visualization of only the active neurotransmitters in the synapse. Any 
unbound sensor would not be visualized as it absorbs at a much lower wavelength.  
 
 
Figure 3-7. Neurotransmitter binding and deprotonation of ExoSensors 
 
In the cytosol, the sensor (A) will exist largely in the deprotonated and unbound 
form (C) due to the neutral pH and relatively low concentration of amines, respectively. 
Both forms A and C would have weak fluorescence as they lack the iminium ion as a 
strong electron acceptor. When the sensor enters the vesicle, it binds to the highly 
concentrated neurotransmitters and produces the iminium ion B. Form B would have 
marginal electron transfer and weak fluorescence since the protonated sulfonamide is a 
weak electron donor. Upon exocytosis, the bound complex enters the synaptic cleft, 
becomes deprotonated (structure D), and produces a marked fluorescence increase due to 
the enhanced ICT. To obtain the maximum fluorescence increase upon exocytosis, the 
sensor pKa must be between the pH of the vesicle (5) and the synaptic cleft (7.4). The 
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sulfonamide functional group was chosen as literature precedent indicated the pKa would 
be approximately 6.
113
 
 
3.6 Synthesis of ExoSensors  
 A series of synthetic schemes were devised in order to achieve a coumarin 
aldehyde sensor with a sulfonamide appended at the 7-position. The first attempt to 
synthesize the sensor was made using nitrogen protecting groups (Figure 3-8). 
 
 
Figure 3-8. Synthetic strategy using carbamate protecting groups 
 
 The strategy was to take 3-aminophenol (17) and protect the nitrogen so that a 
Pechmann reaction with compound 16 would cause cyclization to preferentially occur on 
the oxygen of 17 which is inherently less nucleophilic than the nitrogen. After 
cyclization, we would formylate 19 to make compound 20. Deprotection of the nitrogen 
to make compound 21 would then allow us to do a substitution reaction with a sulfonyl 
chloride to afford the final product. The Pechmann cyclization occurred using 70% 
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H2SO4 at room temperature but would not formylate under either Vilsmeier or Reiche 
conditions. We believe the reasoning was because the electron-withdrawing carbamate on 
19 reduced the nucleophilicity of the alkene (Figure 3-9). 
 
 
Figure 3-9. The carbamate-protected aminocoumarin is deactivated toward Vilsmeier 
formylation 
  
 The next strategy was to use a more electron-donating allyl protecting group 
based on literature precedent (Figure 3-10).
82
 The nitrogen of 3-aminophenol would be 
protected using allyl bromide so that the Pechmann cyclization would occur off of the 
oxygen to form the coumarin body. The sensor would then be formylated, the allyl 
groups removed, and the sulfonyl group appended via a substitution reaction. 
 
 
Figure 3-10. Synthesis strategy using allyl protecting groups 
48 
 
 The allyl groups were placed on the nitrogen in good yield, however, the 
Pechmann cyclization did not go smoothly and provided several unwanted byproducts 
(Figure 3-11). 
 
 
Figure 3-11. Rearranged products from the Pechmann cyclization 
 
 We then chose to add allyl groups to a 7-aminocoumarin (27) that had already 
been cyclized. We would then formylate, deprotect, and append a sulfonyl group (Figure 
3-12). The difficulty arose in removing the allyl protecting groups. After several tries 
using barbituric acid and methane sulfonyl chloride, only small amounts of the mono-
allylated coumarin were isolated. 
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Figure 3-12. Formylation of allyl-protected aminocoumarin 
 
 Given the inefficiency of protecting groups and our difficulties with both 
cyclization and formylation, we decided on a different strategy which was formation of 
the coumarin body using a Claisen condensation which would eliminate the need to 
protect the nitrogen. Therefore, we took 3-aminophenol and acylated using acyl chloride 
to give compound 30 (Figure 3-13). After deacylation of the nitrogen and sulfonation, we 
attempted to do a Claisen condensation, however, only starting material was isolated. The 
reaction mechanism requires that the ketone be deprotonated for the reaction to go 
forward, but we believe that the phenol and sulfonamide were deprotonated first. 
Additional deprotonation of the acyl group (as is necessary to create the enolate 
nucleophile), would cause the molecule to become trianionic which is very unfavorable. 
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Figure 3-13. Claisen condensation of an aryl sulfonamide 
 
 Another synthetic method that doesn’t use protecting groups involved purchasing 
compound 34 which we could triflate, couple to, and then oxidize to the aldehyde (Figure 
3-14). The first two steps worked smoothly, however the oxidation reaction only returned 
starting material. The reaction was successively heated hotter until the starting material 
decomposed. 
 
 
Figure 3-14. Synthesis by oxidizing to the aldehyde 
 
The final ExoSensors were ultimately prepared by combining several of the 
aforementioned strategies (Figure 3-15). First, a Claisen condensation of compound 37 
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formed the coumarin core. Vilsmeier conditions both chlorinated and formylated the ring 
which was then functionalized with a benzene ring via Suzuki coupling. Demethylation 
of the methoxy group followed by triflation of the phenol yielded compound 42. Lastly, 
various sulfonamide substituents were appended using Buchwald-Hartwig coupling 
conditions to produce the final sensors. Both aliphatic and aromatic sulfonamides were 
coupled in hopes of optimizing the fluorescence response produced. It should be noted 
that several amides were also coupled to the coumarin 7-position in case we wrongly 
predicted the pKa of a 7-sulfonamide coumarin. They were not used further, however, due 
to poor water-solubility. 
 
 
Figure 3-15. Synthesis of ExoSensors using a Buchwald-Hartwig coupling strategy 
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3.7 Spectroscopic Results 
3.7.1 pH Titrations  
As mentioned earlier, the pKa of the sensor needs to be between 5.0 and 7.4 in 
order to be protonated in the synaptic vesicle and deprotonated in the synaptic cleft. 
The acidity of the sensor was determined by titrating in aliquots of aqueous HCl or 
NaOH and monitoring the absorbance or fluorescence intensity over a wide pH range. 
Figure 3-16 is a representative example of a pH titration using ExoSensor 517 
(ES517) and monitoring both absorbance and fluorescence. The protonated sensors 
absorb at ~370 nm and deprotonation causes an approximate 50 nm bathochromic 
shift due to the increased charge transfer across the pi-system of the fluorophore. The 
pH was plotted against the absorbance or fluorescence to produce a sigmoidal curve 
where the inflection point represents the pKa. ES517 had the highest pKa of 6.3 and 
the remaining pKa values decreased along with the donating ability of the sulfonyl 
substituent. 
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Figure 3-16. a) UV/vis and b) fluorescence pH titration of ES517 (20 M) in buffer 
(50 mM bis tris propane, 120 mM NaCl, 1% DMSO) adjusting the pH from 3.5 to 
8.6. Inset is the fit to a sigmoidal regression curve where the inflection point 
represents the pKa. 
 
 To test the pKa of the bound sensors, as they would be in the vesicle, ES517 was 
saturated with glutamate and the spectroscopic properties measured over a pH range 
(Figure 3-17). The protonated form of the bound sensor (Figure 3-7, structure B) 
absorbed at 368 nm. Upon deprotonation, two bands were observed at 428 and 458 
nm. The 428 nm band was assigned to the unbound deprotonated form of the sensor 
(structure C). The 458 nm band therefore represents the bound, deprotonated sensor 
(structure D). The plot of pH vs. intensity was fit to a pH isotherm and the pKa 
determined to be 6.3, the same pKa as the unbound sensor. This result indicates that 
binding to the analyte does not affect the acidity of the sensor. All absorption 
wavelengths of the bound and unbound sensors in addition to bound and unbound pKa 
values are reported in Table 3-1. 
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Figure 3-17. a) UV/vis and b) fluorescence pH titration of ES517 (20 M) with 300 
mM glutamate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) 
adjusting the pH from 4.4-7.7. ex = 488 nm. Inset is the fit to a sigmoidal regression 
curve where the inflection point represents the pKa. 
 
Table 3-1. Absorption Wavelengths and pKa Values of 
ExoSensors 
Sensor 
max (nm)
a 
GH/G- 
Unbound 
pKa
b 
Bound 
pKa
c 
ES517 368/419 6.3 6.3 
28 365/420 5.9 6.0 
43 373/418 5.7 5.7 
44 366/416 5.2 5.3 
a
Absorption maxima of the protonated and deprotonated forms of the 
sensor.
  b
pKa values were determined by adding aliquots of aq. HCl or 
NaOH to 20 M sensor in buffer (50 mM bis-tris propane, 120 mM 
NaCl, 1% DMSO). 
c
Glutamate was added (300 mM) to force the sensor 
into the bound state. The complex was monitored over a pH range. 
 
3.7.2 Analyte Titrations 
The ExoSensors were titrated with primary amine neurotransmitters (glutamate, 
norepinephrine, dopamine, and serotonin) and monitored using UV/Vis and 
fluorescence spectroscopy. Summarized in Table 3-2 are the association constants 
(Ka), fluorescent enhancements to analyte addition (Isat/I0), and fluorescent 
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enhancements of the neurotransmitter-bound ExoSensors to pH conditions simulating 
exocytosis (IpH 7.4/IpH 5.0). 
 
Table 3-2. Binding Affinities and Fluorescence Enhancements of ExoSensors 
with Various Primary Amine Neurotransmitters 
 Ka (M
-1
)
a
 Isat / I0
b
 IpH 7.4 / IpH 5.0
c
 
Sensor Glu Nor Dop Ser Glu Nor Dop Ser Glu Nor Dop Ser 
ES517 8.6 49 55 54 12 14 10 0.4 12 5.3 5.5 1.5 
28 3.7 58 76 57 64 8.7 3.3 0.3 5.5 4.2 2.4 0.7 
43 2.8 156 105 110 150 10 4.7 0.7 3.6 2.2 2.1 1.4 
44 3.8 75 11 46 14 2.3 0.5 0.1 1.9 1.3 1.3 1.1 
a
Binding constant of sensor (10 M) with analyte (1.5 M Glu or 100 mM Nor, Dop, Ser) in 
buffer (50 mM bis-tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4); ex = 488 nm. 
b
Fluorescent enhancement upon binding to the analyte. Isat is taken from the theoretical 
maximum of the binding isotherm. 
c
Fluorescent enhancement of sensor (10 M) saturated with 
analyte (300 mM Glu or 100 mM Nor, Dop, Ser) mimicking exocytosis from pH 5.0 to pH 7.4; 
ex = 488 nm. Glu = glutamate, Nor = norepinephrine, Dop = dopamine, Ser = serotonin. 
 
Addition of all amine analytes induced a bathochromic shift of ~40 nm in the 
absorbance indicating formation of the iminium ion from the coumarin aldehyde 
(Figure 3-18). The sensors bound to all amine analytes, however, with varying 
degrees of affinity. Glutamate, the only amino acid, bound to all sensors with weak 
affinity (<10 M
-1
) while the remaining biogenic amines bound with double- or triple-
digit association constants. The weaker binding of glutamate is likely due to the 
reduced nucleophilicity of nitrogen and intramolecular electrostatic interaction with 
the alpha carboxylate. Lower binding constants, however, are actually preferred to 
allow continuous monitoring of vesicular glutamate concentrations which have been 
measured from 50-210 mM.
51-52 
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Figure 3-18. a) UV/vis and b) fluorescence titration of ES517 (20 M) in buffer (50 
mM bis-tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-800 L 
aliquots of 1.5 M glutamate. ex = 488 nm. Inset is the fit to a one-site binding 
isotherm. 
 
The fluorescence intensity increased with the addition of most amine analytes 
when excited at 488 nm, a wavelength that is commonly available with standard 
microscopy setups and long enough to excite only the bound deprotonated sensor. 
The only analyte exception was serotonin, which possesses an electron-rich indole 
that tends to quench fluorescence through photoinduced electron transfer (PET). The 
fluorescence enhancements upon analyte addition trend such that glutamate > 
norepinephrine > dopamine > serotonin. 
Given that ES517 possessed the most optimal spectroscopic properties, it was 
monitored with additional analytes and the key results are presented in Table 3-3. As 
with the non-pH-sensitive NS521, all primary amine neurotransmitters bound 
relatively weakly with a preference for aromatic neurotransmitters. By contrast, the 
non-aromatic neurotransmitters produced the largest change in fluorescence upon 
binding at pH 7.4 due to PET quenching effects from the electron-rich aromatic 
groups. Importantly, all non-aromatic neurotransmitters produced large fluorescence 
increases upon pH change from 5.0 to 7.4. The catecholamines gave smaller, but still 
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significant fluorescence increases and serotonin was unique in that it gave little 
fluorescence change (Figure 3-19). Taken together, our results suggest that ES517 is 
the best candidate to directly visualize glutamate release as it would provide the 
greatest turn-on fluorescence response to exocytosis. 
 
Table 3-3. Binding and spectroscopic properties of ES517 with 
various primary amine neurotransmitters 
Neurotransmitter
a
 Ka (M
-1
)
 
Isat/I0
b
 IpH7.4/IpH 5
c
 
glutamate 8.6
 
12 12
d 
GABA 8.3
 
27 11
 d 
glycine 9.2
 
25 10
 d 
norepinephrine 49
 
14 5.3
 e 
dopamine 55
 
10 5.5
 e 
serotonin 54
 
0.5 1.5
 e 
aBinding studies of ES517 (20 μM) with saturating amounts of analyte in buffered 
conditions (50 mM bis-tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) with 
10% error based on triplicate titration. bFluorescence enhancement upon binding 
analyte at pH 7.4 (Isat taken from the theoretical max of the binding isotherm). em = 
517 nm. 
cRatio of fluorescence at pH 7.4 vs. 5.0 of ES517 (20 μM) saturated with 
analyte. 
d
Saturated with 300 mM analyte. 
e
Saturated with 100 mM analyte. 
 
 
Figure 3-19. Fluorescence enhancements of ES517 saturated with various amine 
analytes under pH conditions simulating exocytosis. 
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3.7.3 Response to Exocytosis 
The most important parameter tested was the fluorescence increase of the analyte-
bound sensor when changing the pH from 5 to 7.4 (IpH 7.4 / IpH 5.0) which mimics 
neurotransmitter release from the acidic vesicle to the neutral synapse. The glutamate-
bound ES517 gave the greatest fluorescence enhancement over the pH range than did 
all other sensor-amine combinations. There was a clear correlation between the pKa of 
the sensor and the pH jump from 5 to 7.4 that mimics the release of the 
neurotransmitter from the vesicle to the synaptic cleft (Figure 3-20).  
The ratio of IpH 7.4 / IpH 5.0 is the greatest for ES517 because it has the highest pKa. 
The fluorescence intensity at pH 5.0 is much lower due to the majority of the sensor 
molecules being protonated. Therefore, when you divide by a smaller denominator, 
the result is a greater fluorescence enhancement. The thiophene-substituted sensor, on 
the other hand, has a pKa of ~5 which means that in the vesicle, approximately half of 
the sensor molecules are already deprotonated and contributing to higher background 
fluorescence. 
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Figure 3-20. Relationship between the sensor pKa and 
the fluorescence change of the bound sensor under 
conditions mimicking exocytosis (I pH 7.4 / I pH 5.0). 
Dop = dopamine, Nor = norepinephrine, Glu = 
glutamate. Serotonin quenches fluorescence and is 
therefore not shown in the comparison. 
 
3.8 Cellular Analysis 
 The practical use of this method was evaluated by incubating ES517 with live 
norepinephrine-secreting chromaffin cells. Chromaffin cells are taken from the adrenal 
glands but remain one of the standard models used to study cellular exocytosis of 
norepinephrine and epinephrine because they function similar to neuronal cells and are 
easily obtained. The cells were imaged using both confocal and total internal reflection 
fluorescence (TIRF) microscopies (Figure 3-21). In confocal microscopy, light from a 
laser is passed through a pinhole, reflected by a mirror, and focused on a small spot on 
the specimen. This technique allows for the depth of field to be tightly controlled during 
imaging. On the other hand, TIRF directs the laser light at a critical incident angle so that 
nearly all of the light is reflected back. This critical angle is achieved by considering the 
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refractive indices of the materials at the interface (i.e. aqueous media and a glass slide). 
When total internal reflection occurs, an evanescent wave is produced which illuminates 
only fluorophores within ~100 nm of the interface. This technique provides low 
background as only a shallow slice of the sample is imaged and we believed it would aid 
in visualizing events occurring at individual vesicles within a secretory cell. 
 Confocal fluorescence microscopy of the cells revealed punctate fluorescence, 
similar to that seen for NS521 (Figure 3-21a,b). We believe this is due to the 
accumulation of ES517 within secretory vesicles. TIRF imaging also shows punctate 
fluorescence with very low background. These preliminary studies are promising and 
future work will include excitation of the cells to induce exocytosis. We would first have 
to confirm that ES517 has accumulated within the secretory vesicles, then reduce the 
laser power so that a turn-on fluorescence response could be visualized upon stimulation. 
A variety of reagents could be used either to stimulate exocytosis or collapse the pH 
gradient of the vesicle including potassium chloride, chloroquine, nicotine, and reserpine. 
Electrical stimulation could also be used. If these studies go as expected, we will have 
produced the first fluorescent molecular logic gate that directly detects the release of 
neurotransmitters. 
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Figure 3-21. ES517 in live norepinephrine-secreting chromaffin cells viewed by a) 
confocal fluorescence microscopy, b) brightfield, and. c) total internal reflection 
fluorescence (TIRF) microscopy. d) Explanation of TIRF. A critical incident angle of 
light must be directed at the sample in order to achieve total internal reflection. This 
produces an evanescent wave that excites only the fluorophores within ~100 nm of 
the interface. 
 
In summary, a series of two-input fluorescent molecular logic gates were 
developed for the visualization of neurotransmitters released upon exocytosis. The design 
strategy exploits high vesicular neurotransmitter concentrations and the pH gradient 
between the vesicle and synaptic cleft. When bound to glutamate, ES517 afforded a 12-
fold fluorescence enhancement to conditions mimicking synaptic release and further 
studies are underway to optimize the fluorescence response to quenching analytes. ES517 
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serves as a potential research tool for studying the mechanisms underlying 
neurotransmission. Preliminary in vitro tests in chromaffin cells show potential and we 
hope to further investigate the utility of these sensors in neurons and brain slices. 
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CHAPTER FOUR 
Three-Input Molecular Logic Gates for Glutamate & Zinc Corelease 
 
 
 
4.1 Background 
Glutamate, the primary excitatory neurotransmitter, mediates roughly half of all 
synaptic transmissions in the central nervous system and affects learning, memory, motor 
control, and cognition.
114
 There exists a subset of glutamatergic neurons in the forebrain 
(~10%) that contain high concentrations of glutamate and zinc which are coreleased into 
the synaptic cleft.
115,116,117
 Zinc, also an important neuromodulator, affects enzyme 
catalysis, gene expression regulation, neural tissue growth and development, and 
modulation of brain excitability through effects on voltage-gated calcium channels 
118,116b,115
 Moreover, researchers have recently observed correlations between synaptically 
released zinc and increased concentrations of hyperphosphorylated tau, the chief 
component of neurofibrillary tangles in Alzheimer’s disease (AD).119 It also promotes 
oligomerization of amyloid-β, also a known contributor to AD (Figure 4-1). 120 
Therefore, understanding the specific contributions of zinc in the neuronal synapse could 
elucidate disease-causing mechanisms. 
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Figure 4-1. Zn
2+
-mediated amyloid-β oligomerization and disruption of physiology by 
formation of amyloid-β-Zn2+ complexes. Zinc can encounter amyloid-β upon 
glutamatergic neurotransmission and form oligomers. The greater the zinc concentration, 
the more insoluble the oligomer. Sequestration of zinc from its normal targets can disrupt 
physiology necessary for memory events among other things. APP = β-amyloid precursor 
protein; ZnR = metabotropic Zn
2+
-sensing receptor, ZnT3 = Zn
2+
 transporter 3. 
 
However, much is still unknown as to zinc accumulation and release from 
synaptic vesicles. Zinc-containing glutamatergic neurons are heavily studied, particularly 
with respect to the fate of the zinc ions post-exocytosis. To selectively image transmitter 
release from these neurons, in the presence of zinc-independent glutamatergic neurons, it 
would be necessary to build a sensor that not only responds to both zinc and glutamate, 
but also to the change in pH upon exocytosis. Here, we report a series of three-input 
AND fluorescent molecular logic gates that serve as a proof-of-concept for directly 
imaging the corelease of glutamate and zinc from glutamatergic secretory vesicles. The 
molecular logic gates described here are designed to exploit the copackaging of highly 
concentrated glutamate and zinc in glutamatergic boutons in order to directly visualize 
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their corelease upon exocytosis. Information about glutamate and zinc corelease would 
offer significant insight into the mechanisms underlying neurotransmitter dysregulation 
and the progression of neurodegenerative diseases without altering transmission activity. 
 
4.2 Previous Work  
 Recently, we have developed a series of increasingly-sophisticated fluorescent 
molecular logic gates for the direct visualization of primary amine neurotransmitters 
(Figure 4-2).
46, 121
 The sensors consist of a coumarin core with functionalities integrated 
into the fluorophore π-system. The sensor aldehyde reversibly binds to primary amine 
neurotransmitters under physiological conditions to create a positively-charged iminium 
ion which induces a large bathochromic shift in absorbance. By exciting at the new, 
longer wavelength, a fluorescence increase is observed due to the enhanced internal 
charge transfer (ICT) across the π-system.  
NS521 was developed as a single-input YES fluorescent molecular logic gate for 
the direct visualization of norepinephrine and dopamine.
46
 The sensor capitalizes on the 
high concentrations of catecholamines (0.5 – 1.0 M) and acidic environment within 
secretory vesicles of specialized cells in order to afford selective labeling over typical 
cellular amines which are present at significantly lower concentrations.
52,122,123,51,56
 We 
extended the utility of this method to sense neurotransmitter release by developing 
ES517, a dual-input AND molecular logic gate.
121
 ES517 incorporates a pH-sensitive 
functionality into the coumarin-3-aldehyde scaffold and only fluoresces upon 
concomitant neurotransmitter binding and the pH change associated with exocytosis. 
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Release of the bound complex from the acidic vesicle (pH 5) into the neutral synaptic 
cleft (pH 7.4) would allow for direct visualization of only released neurotransmitters.  
 
 
Figure 4-2. a) Molecular logic gates for neuronal imaging. Nor = norepinephrine, Glu = 
glutamate, fluor = fluorescence output,  pH = increase in pH from 5.0 to 7.4 (mimics 
exocytosis from the acidic vesicle to the synaptic cleft). 
 
4.3 Sensor Design 
 The three-input AND gates (56a-d) respond to glutamate, zinc, and pH through 
functional groups that are integrated into the π-system of the fluorophore (Figure 4-3). 
The aldehyde at the coumarin 3-position reversibly forms imines with glutamate and 
thereby, creates a multi-point binding pocket with the lactone carbonyl oxygen with 
which zinc can coordinate in a cooperative fashion.
124
 The hydroxyl group at the 7-
position imparts pH-sensitivity which acts as the final switch for a turn-on fluorescence 
response. Deprotonation of the hydroxyl group increases the absorbance ~45 nm, 
permitting selective visualization of only the deprotonated species. The sensor-glutamate-
zinc bound complex would be weakly fluorescent until exocytosis when the increase in 
pH would switch the fluorescence on. Methyl groups were appended to the coumarin 
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body to increase absorption wavelengths and therefore optimize the fluorescence 
response when using a specific laser wavelength. 
 
 
 
Figure 4-3. Logic gate and truth table for three-input AND gates. The molecular logic 
gates respond only upon concomitant neurotransmitter (NT) binding, Zn
2+
 coordination, 
and the pH change associated with exocytosis.  pH = pH increases from 5 to 7.4. 
 
4.4 Synthesis 
 The hydroxysalicylaldehyde starting materials (52a-d) for the 3-input AND gates 
were synthesized following literature precedent (Figure 4-4).
125
 Methylation of this 
aromatic core was achieved through a simple series of straightforward formylation and 
reduction steps until the desired number of methyls were appended. Again, the purpose of 
the methyl groups is to shift the absorption of the sensors for optimization toward specific 
microscope wavelengths. 
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Figure 4-4. Synthesis of hydroxysalicylaldehyde starting materials for 3-input AND 
molecular logic gates. 
 
Subsequent treatment of 52a-d with diethylglutaconate and base induced an Aldol 
reaction followed by intramolecular transesterification to produce the coumarin body 
(Figure 4-5). Protection of the phenolic oxygen was achieved using acetic anhydride 
which allowed for oxidative cleavage of the alkene using osmium tetroxide and sodium 
periodate. Deprotection of the phenol was achieved using ammonium acetate and 
methanol/water (4:1) to yield the final products (56a-d). 
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Figure 4-5. Second part of synthesis for the 3-input molecular AND logic gates. 
 
4.5 Titrations 
 pH and analyte titrations were conducted and the representative spectra of 
ExoSensor 470 (ES470, 56c) are shown. Deprotonation of the sensors caused a large 
bathochromic shift in the absorbance and a concomitant increase in fluorescence when 
excited at the deprotonated wavelength. Each additional methyl group added ~10 nm to 
the excitation maximum and proved to be an effective method for tailoring the sensors 
toward a specific excitation wavelength. In this case, we optimize the sensors for the 440 
nm laser line as it is one of the standard wavelengths in many microscopy setups. 
The titration of ES470 with glutamate gave an absorbance increase at 452 nm; 
however, the fluorescence emission decreases which is opposite of the response obtained 
for coumarin aldehydes containing substituents at the 4-position (Figure 4-6).
46,48
  
Coumarin aldehydes with C4 substituents (structure A) lead to a rigid iminium ion with a 
high quantum yield, resulting in strong fluorescence.
126
 However, ES470 lacks a 
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substituent at the 4-position (structure B) which results in free rotation of the imine and 
weak fluorescence.  
 
 
Figure 4-6. a) UV/vis (20 M) and b) fluorescence (1 M) titration of ES470 in buffer 
(50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4) adding 20-800 L aliquots 
of 1.5 M glutamate. ex = 440 nm. Inset is the fit to a one-site binding isotherm. c) 
Substituents at the coumarin 4-position inhibit free rotation of the imine. EDG = electron-
donating group. 
 
Adding aliquots of zinc acetate to the ES470-glutamate complex induces a 
hypsochromic shift in both the absorption and fluorescence maxima as well as a modest 
fluorescence increase (Figure 4-7). Addition of zinc rigidifies the fluorophore and locks 
the π-system into place, resulting in the fluorescence increase. The presence of zinc in the 
binding pocket prevents protonation of the imine which is otherwise protonated at 
physiological pH. We hypothesize that this change in protonation state mitigates the 
electron transfer across the fluorophore and induces the small blue shift in the spectra. A 
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control experiment was performed in which zinc was added to ES470 alone and no 
fluorescence change was observed.  
 
 
Figure 4-7. a) UV/vis (20 M) and b) fluorescence (1 M) titration of ES470 (56c) with 
300 mM glutamate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 
5.0) adding 5-8 L aliquots of 1.1 M zinc acetate. ex = 393 nm. Inset is the fit to a one-
site binding isotherm. 
 
Table 4-1 details the results from pH and binding titrations with sensors 56a-d. 
Excitation and emission wavelengths increase ~10 nm with each additional methyl group, 
demonstrating an effective technique to tune chemosensors for specific excitation 
wavelengths used in conventional microscopy setups. The pKa values of the three-input 
sensors were all approximately 6 which suits neuronal studies, as they will be protonated 
in the secretory vesicle (pH 5) and deprotonated in the synaptic cleft (pH 7.4). Glutamate 
binding constants were all single-digit values which agrees with previously-obtained 
binding constants of coumarin aldehydes with glutamate.
46, 48
 The binding of zinc to the 
sensor-glutamate complex was comparable for all sensors and ranged from 24-32 M
-1
. 
While these binding constants appear low, they are actually preferred for reversible 
analyte detection because glutamate and zinc are found in hundreds of millimolar and 
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low millimolar concentrations, respectively, within glutamatergic secretory vesicles.
51-52, 
122-123,127
 
 
 
Table 4-1. Spectroscopic and Binding Properties of Sensors 56a-d 
Sensor 
ex,em 
(nm)a 
pKa 
Ka (Glu) 
(M-1)b 
Kapp (Zn
2+) 
(M-1)c 
IpH 7.4 / 
IpH 5.0
d 
56a 436,462 6.0 2.1 24 6.7 
56b 444,472 6.1 2.6 27 9.3 
56c 
(ES470) 
451,470 6.1 2.8 30 11 
56d 462,480 5.7 2.7 32 5.8 
aFluorescence excitation and emission maxima of sensors 1a-d (1 M) in buffer (50 mM bis-tris 
propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 440 nm; 
bBinding of sensors 1a-d (1 M) to 
glutamate (Glu) in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4); 
cApparent binding of sensors 1a-d (1 M) and glutamate (300 mM) to zinc acetate in buffer (50 
mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 5.0); dFluorescence intensity of a mixture of 
sensors 1a-d (1 M), glutamate (500 mM) and zinc acetate (40 mM) monitored at pH 5.0 and 7.4. 
ex = 440 nm. 
 
The key parameter to note is the change in fluorescence intensity (IpH 7.4/IpH 5.0) of 
the sensor-glutamate-zinc complex over the pH range associated with exocytosis of the 
vesicle. This value indicates the factor by which the fluorescence should increase upon 
exocytosis of the fully bound complex. The greatest fluorescence enhancement was 
observed with ES470 at 11-fold. 
The potential fluorescence outputs of ES470 are shown in Figure 4-8. Bars a-d 
represent the fluorescence intensity of ES470 in various states before exocytosis (pH 5.0) 
and bars e-h represent the fluorescence intensity after exocytosis (pH 7.4). Bar h shows 
the only combination of inputs that gives a fluorescence turn-on response above the 
ON/OFF threshold using exocytotic pH conditions. Bar e depicts the next highest 
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fluorescence response; however, the unbound sensor is chargeless and would not 
accumulate within acidic secretory vesicles, but would instead be washed away during 
pre-imaging cell preparations.
46
 The sensor-zinc complex (bar g) would also not be 
present given the high concentration of glutamate within glutamatergic vesicles 
(hundreds of millimolar).
51-52, 56, 122-123 
Therefore states e and g are not even relevant to 
imaging applications. 
 
 
Figure 4-8. Relative fluorescence intensities and truth table for 1c, a three-input AND 
gate. Samples contained ES470 (1 M) in buffer (50 mM HEPES, 120 mM NaCl, 1% 
DMSO) in the presence or absence of glutamate (Glu, 500 mM) and zinc acetate (Zn
2+
, 
40 mM).  pH = increase in pH from  5.0 to 7.4 to mimic exocytosis from the acidic 
vesicle to the synaptic cleft. 
 
To further probe the binding interaction between the sensor, the amine, and zinc, 
titrations were repeated with other primary amine analytes (Table 4-2). When added to 
ES470, all of the amines decreased the fluorescence intensity by ~65-70%, as seen with 
glutamate. Furthermore, there was indication that the amines containing an -carboxylate 
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bound better to the added zinc than did amines lacking an -carboxylate functional 
group. Glutamate was still shown to have the highest fluorescence enhancement (IpH 
7.4/IpH 5.0) under conditions mimicking exocytosis compared to the other analytes. We also 
evaluated the effect of zinc binding on the sensor-amine complex (IGlu-Zn
2+
/IGlu). For 
amines containing an -carboxylate, zinc addition increased fluorescence, but for amines 
lacking the -carboxylate, zinc addition decreased fluorescence. This result also indicates 
that the -carboxylate plays an important role in enabling proper zinc coordination to 
occur. 
 
Table 4-2. Spectroscopic and Binding Properties of ES470 (56c) with Various Amine 
Analytes 
Amine 
Ka (amine)  
(M
-1
)
a 
Kapp (Zn
2+
) 
(M
-1
)
b 
IpH7.4 / 
IpH 5.0
c 
IGlu-Zn
2+
 / 
 IGlu
d 
 
N-butylamine 
0.8 - 6 0.36 
 
GABA 
1.6 - 8 0.37 
 
aspartic acid 
1.9 24 11 1.09 
 
glutamic acid 
2.8 30 11 2.82 
 
2-aminoadipic acid 
2.2 26 9 2.16 
a
Binding constant of sensor ES470 (1 M) to various amine guests in buffer (50 mM bis-tris propane, 120 
mM NaCl, 1% DMSO, pH 7.4);
 b
Apparent binding of ES470 (1 M) and amine guest (300 mM) adding 
aliquots of 1.1 M zinc acetate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 5.0);
 
c
Fluorescence intensity of ES470 (1 M), glutamate (500 mM), and zinc acetate (40 mM) monitored at pH 
5.0 and 7.4. ex = 440 nm. The enhancement represents the fluorescence increase upon exocytosis; 
d
Ratio 
of the fluorescence intensity of the ES470-amine complex with and without Zn
2+
. ex = 440 nm. 
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In conclusion, sensors 56a-d were designed and synthesized as water-soluble 
three-input AND molecular logic gates for the purpose of neuronal imaging. The sensors 
are easily modified to incorporate multiple functionalities that are integrated into the 
fluorophore π-system which directly modulate the optical properties upon interaction 
with analyte. The unique sensing mechanism capitalizes on the large quantities of 
glutamate already packaged in zinc-containing secretory vesicles to create a reversible 
binding pocket for zinc which is only visualized upon release into the synaptic cleft. The 
molecular logic-based approach is a proof-of-concept that may serve as a useful 
prototype from which other bioanalyte detection systems can be constructed. 
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APPENDIX 
Experimental Procedures and Characterization Data 
 
 
 
Part I. General Information 
All reagents and solvents were purchased from commercial sources and used 
without further purification unless stated otherwise. Anhydrous dichloromethane, 
acetonitrile, and triethylamine were obtained by distillation from CaH2. Anhydrous THF 
and toluene were obtained by distillation from sodium metal and benzophenone. All 
reactions were conducted using oven or flame dried glassware and under N2 atmosphere 
unless stated otherwise. Flash column chromatography was carried by using 32-63 μm 
silica gel.  
NMR spectra were obtained by a Bruker ARX-250 MHz, DRX-300 MHz, or 
DRX-500 MHz in CDCl3 or DMSO-d6 using tetramethylsilane (TMS) as a reference. IR 
spectra were obtained by a Thermo Scientific Auxiliary Equipment Module (AEM) for 
Nicolet FT-IR spectrometers. High resolution mass spectra (HRMS) were carried by a 
Bruker Apex-Qe FTMS at the Old Dominion University in Norfolk, VA. 
 
Part II. Spectroscopic Studies 
UV-Visible spectra were obtained by a Varian Cary-1E UV-Visible spectrometer. 
Fluorescence spectra were obtained by a Shimadzu RF-5301 PC spectrofluorimeter. 
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Titrations were performed by using bis tris propane or HEPES buffer with NaCl or 
Na2S2O3 added unless otherwise stated. Absorbance and fluorescence spectra were 
processed using SigmaPlot™ 12.3 and best-fit lines fit using GraphPad Prism 6.01. 
 
Analyte Titrations 
Analyte Titrations for 3-Formyl-7-hydroxy-4-phenylcoumarin (41) 
Wavelength (nm)
360 380 400 420 440 460 480 500 520
A
b
s
o
rb
a
n
c
e
0.0
0.1
0.2
0.3
0.4
0.5
 Wavelength (nm)
500 550 600 650
In
te
n
s
it
y
 (
a
rb
.)
0
100
200
300
400
 
Figure A-1. (a) UV/vis and (b) fluorescence titration of compound 41 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 1.5 M glutamate. ex = 450 nm. 
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Figure A-2. (a) UV/vis and (b) fluorescence titration of compound 41 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM norepinephrine. ex = 450 nm. 
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Figure A-3. (a) UV/vis and (b) fluorescence titration of compound 41 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM dopamine. ex = 450 nm. 
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Figure A-4. (a) UV/vis and (b) fluorescence titration of compound 41 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM serotonin. ex = 450 nm. 
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Analyte Titrations for ES517 
 
Figure A-5. Fluorescence titration of ES517 (20 μM) 
with 20-800 μL of 1.5 M GABA in buffer (50 mM bis 
tris propane, pH 7.4, 50 mM Na2S2O3, 1% DMSO).  
ex = 488 nm.  Inset is the fit to a binding isotherm. 
em = 514 nm. 
 
 
Figure A-6. Fluorescence titration of ES517 (20 μM) 
with 20-800 μL of 1.5 M glycine in buffer (50 mM bis 
tris propane, pH 7.4, 50 mM Na2S2O3, 1% DMSO).  
ex = 488 nm.  Inset is the fit to a binding isotherm. 
em = 515 nm. 
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Figure A-7. Fluorescence titration of ES517 (20 μM) 
with 20-220 μL of 100 mM norepinephrine in buffer 
(50 mM bis tris propane, pH 7.4, 50 mM Na2S2O3, 1% 
DMSO).  ex = 488 nm.  Inset is the fit to a binding 
isotherm. em = 515 nm. 
 
   
Figure A-8. Fluorescence titration of ES517 (20 μM) 
with 20-220 μL of 100 mM dopamine in buffer (50 mM 
bis tris propane, pH 7.4, 50 mM Na2S2O3, 1% DMSO).  
ex = 488 nm.  Inset is the fit to a binding isotherm. em 
= 513 nm. 
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Figure A-9. Fluorescence titration of ES517 (20 μM) 
with 20-220 μL of 100 mM serotonin in buffer (50 mM 
bis tris propane, pH 7.4, 50 mM Na2S2O3, 1% DMSO).  
ex = 488 nm.  Inset is the fit to a binding isotherm. em = 
514 nm. 
 
 
Analyte Titrations for 3-Formyl-4-methylsulfonamide-4-phenylcoumarin (28) 
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Figure A-10. (a) UV/vis and (b) fluorescence titration of compound 28 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 1.5 M glutamate. ex = 488 nm.  
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Figure A-11. (a) UV/vis and (b) fluorescence titration of compound 28 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM norepinephrine. ex = 488 nm.  
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Figure A-12. (a) UV/vis and (b) fluorescence titration of compound 28 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM dopamine. ex = 488 nm.  
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Figure A-13. (a) UV/vis and (b) fluorescence titration of compound 28 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM serotonin. ex = 488 nm. 
 
 
Analyte Titrations for 3-Formyl-4-phenyl-7-phenylsulfonamidecoumarin (43) 
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Figure A-14. (a) UV/vis and (b) fluorescence titration of compound 43 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 1.5 M glutamate. ex = 488 nm. 
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Figure A-15. (a) UV/vis and (b) fluorescence titration of compound 43 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM norepinephrine. ex = 488 nm.  
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Figure A-16. (a) UV/vis and (b) fluorescence titration of compound 43 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM dopamine. ex = 488 nm.  
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Figure A-17. (a) UV/vis and (b) fluorescence titration of compound 43 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM serotonin. ex = 470 nm.  
 
 
Analyte Titrations for 3-Formyl-4-phenyl-7-thiophenesulfonamidecoumarin (44) 
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Figure A-18. (a) UV/vis and (b) fluorescence titration of compound 44 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 1.5 M glutamate. ex = 488 nm. 
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Figure A-19. (a) UV/vis and (b) fluorescence titration of compound 44 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM norepinephrine. ex = 470 nm.  
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Figure A-20. (a) UV/vis and (b) fluorescence titration of compound 44 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM dopamine. ex = 488 nm.  
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Figure A-21. (a) UV/vis and (b) fluorescence titration of compound 44 (10 M) in buffer 
(50 mM bis tris propane, 50 mM Na2S2O3, 1% DMSO, pH 7.4) adding 20-220 uL 
aliquots of 100 mM serotonin. ex = 488 nm.  
 
 
 Analyte Titrations for Compounds 56a,b,d with Glutamate 
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Figure A-22. Fluorescence titration of 56a (1 M) adding 20-800 L aliquots of 1.5 M 
glutamate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm. 
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Figure A-23. Fluorescence titration of 56b (1 M) adding 20-800 L aliquots of 1.5 M 
glutamate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm. 
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Figure A-24. Fluorescence titration of 56d (1 M) adding 20-800 L aliquots of 1.5 M 
glutamate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm. 
 
 
 
 
 
[Glutamate] (M)
0.0 0.2 0.4 0.6 0.8 1.0 1.2
1
-(
I/
I0
)
0.0
0.2
0.4
0.6
0.8
[Glutamate] (M)
0.0 0.2 0.4 0.6 0.8 1.0 1.2
1
-(
I/
I 0
)
0.0
0.2
0.4
0.6
0.8
89 
 
Analyte Titrations for Amine-Bound Compounds 56a-d Upon Adding Zinc 
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Figure A-25. Fluorescence titration of 56a (1 M) and 300 mM glutamate adding 5-8 L 
aliquots of 1.1 M zinc acetate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% 
DMSO, pH 5.0). ex = 380 nm. Inset is the fit to a one-site binding isotherm. 
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Figure A-26. Fluorescence titration of 56b (1 M)  and 300 mM glutamate adding 5-8 
L aliquots of 1.1 M zinc acetate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% 
DMSO, pH 5.0). ex = 380 nm. Inset is the fit to a one-site binding isotherm. 
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Figure A-27.  Fluorescence titration of 56d (1 M) and 300 mM glutamate adding 5-8 
L aliquots of 1.1 M zinc acetate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% 
DMSO, pH 5.0). ex = 390 nm. Inset is the fit to a one-site binding isotherm.  
 
 
 
  
Figure A-28. Fluorescence titration (1 M) of ES470 (56c) with 300 mM glutamate in 
buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 5.0) adding 5-8 L 
aliquots of 1.1 M zinc acetate. ex = 393 nm. Inset is the fit to a one-site binding 
isotherm. 
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Analyte Titrations for ES470 (56c) with Various Amine Analytes 
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Figure A-29. Fluorescence titration of ES470 (1 M) adding 20-800 L aliquots of 1.5 
M glycine in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm.  
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Figure A-30. Fluorescence titration of ES470 (1 M) adding 20-800 L aliquots of 1.5 
M aspartate in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm.  
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Figure A-31. Fluorescence titration of ES470 (1 M) adding 20-800 L aliquots of 1.5 
M GABA in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). ex = 
440 nm. Inset is the fit to a one-site binding isotherm.  
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Figure A-32. Fluorescence titration of ES470 (1 M) adding 20-800 L aliquots of 1.5 
M N-butylamine in buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO, pH 7.4). 
ex = 440 nm. Inset is the fit to a one-site binding isotherm.  
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pH Titrations 
pH Titration of 3-Formyl-7-methylsulfonamide-4-phenylcoumarin (28) 
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Figure A-33. (a) UV/vis and (b) fluorescence pH titration of compound 28 (20 M) in 
buffer (50 mM bis tris propane, 120 mM NaCl, 1% DMSO) adding aliquots of 1-12 M 
HCl from pH 8.5 to 3.7.  ex = 420 nm.  
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Figure A-34. (a) UV/vis and (b) fluorescence pH titration of compound 43 (20 M) in 
buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding aliquots of 1-12 M 
HCl from pH 8.4 to 2.7.  ex = 425 nm.  
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pH Titration of 3-Formyl-4-phenyl-7-thiophenesulfonamidecoumarin (44) 
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Figure A-35. (a) UV/vis and (b) fluorescence pH titration of compound 44 (20 M) in 
buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding aliquots of 1-12 M 
HCl from pH 7.7 to 3.5.  ex = 416 nm. 
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Figure A-36. (a) UV/vis and (b) fluorescence pH titration of compound 41 (20 M) in 
buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding aliquots of 1-12 M 
HCl from pH 8.8 to 3.2.  ex = 420 nm. 
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pH Titration of 3-formyl-7-hydroxycoumarin (56a) 
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Figure A-37. a) UV/vis (20 M) and b) fluorescence titration (1 M) of 56a in buffer (50 
mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding 1 L aliquots of aq. NaOH. ex 
= 416 nm. Inset is the fit to a sigmoidal regression curve. 
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Figure A-38. a) UV/vis (20 M) and b) fluorescence (1 M) titration of 56b in buffer 
(50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding 1 L aliquots of aq. NaOH. 
ex = 426 nm. Inset is the fit to a sigmoidal regression curve. 
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pH Titration of 3-formyl-7-hydroxy-5,6-dimethylcoumain (ES470, 56c) 
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Figure A-39. a) UV/vis (20 M) and b) fluorescence (1 M) pH titration of ES470 in 
buffer (50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding 1 L aliquots of aq. 
NaOH.  ex = 440 nm.  Inset is the fit to a sigmoidal regression curve. 
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Figure A-40. a) UV/vis (20 M) and b) fluorescence (1 M) titration of 56d in buffer 
(50 mM bis-tris propane, 120 mM NaCl, 1% DMSO) adding 1 L aliquots of aq. NaOH. 
ex = 438 nm. Inset is the fit to a sigmoidal regression curve. 
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pH Titration of the Glutamate-Bound 3-Formyl-7-methoxy-4-phenylcoumarin (40) 
(to determine the pKa of the iminium ion) 
 
  
Figure A-41. (a) UV/vis titration and (b) fit to a sigmoidal regression curve for 
compound 40 (20 μM) and 0.5 M glutamate adding aliquots of 1-8 M NaOH in 
buffer (50 mM bis tris propane, 120 mM NaCl). pKa = 9.1 
 
 
Part III. Binding Constant Determination 
 
 
For host (H) – guest (G) binding studies, the data was fit to a 1:1 binding 
isotherm. Equation 1 shows the relationship between concentrations of bound and 
unbound host and guest species and the association constant (Ka). 
 
                 (Eq. 1) 
 
 For our experiments, [G] is much larger than  the Ka  meaning that G is virtually 
free at all concentrations used in the experiment. Therefore,  Gfree = Gtotal, and the plot of 
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Gtotal vs. the fluorescence (I/I0) provides a hyperbolic curve where the Kd is equal to the 
concentration of G at half-saturation (Figure A-42). The guest concentration at which the 
sensor is half bound is equal to the dissociation constant (Kd). The dissociation constant is 
inversely related to the association constant as described in Equation 2. Therefore, in the 
example below, the Ka would be 1/0.006 or 167 M
-1
. 
 
 
Figure A-42. Sample binding isotherm from a host-guest fluorescence titration 
 
                     (Eq. 2) 
 
 Equation 3 is used to solve for the dissociation constant. Bmax is the theoretical 
maximum of the Y-axis if the parabolic were to go on to infinity. F0 is the initial 
fluorescence output with no guest present, and F is the fluorescence output at a given 
concentration of guest. 
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                                          (Eq. 3) 
 
Part IV. pKa Determination 
 The pKa values were determined from either the UV/vis or fluorescence spectra. 
The pH was measured after addition of each aliquot of acid or base and the absorbance or 
fluorescence intensity was observed. Plotting the pH versus the absorbance or 
fluorescence intensity yields a sigmoidal shape (Figure A-43) to which a best-fit 
regression curve is assigned . The theoretical maximum and minimum of the best fit line 
are determined and the pH that corresponds with the inflection point represents the pKa 
value for the given compound. 
 
 
Figure A-43. Sigmoidal regression from a sample pH titration. 
 
 The regression curve used to determine the pKa is shown in Equation 4. X is the 
logarithm of the pH value and Y is the response (i.e. absorbance or fluorescence 
intensity). The LogEC50 is the logarithm of the effective concentration (or the pH) at 
100 
 
which the response is half way (50%) between the maximum and minimum Y values. 
The standard slope used means that the response goes from 10-90% of max for every two 
log units. 
 
                                           Eq. 4 
 
Part V. Cellular Analyses 
 Cellular analyses were performed using bovine adrenal chromaffin cells from a 
local slaughterhouse. Chromaffin cells are a standard model for studying exocytosis as 
the adrenal gland secretes hormones, i.e., epinephrine (EP) & norepinephrine (NE), that 
are packaged at high concentrations similar to neurotransmitters in neuronal vesicles.
51-
52,53, 128
  
 The chromaffin cells were isolated from the adrenal glands using the following 
procedure:
129
 
1. Inject a buffered solution of collagenase type P (1 mg/mL, Roche Diagnostics) 
into the portal vein. Shake glands at 37 °C for 20 min. 
2. Cut around the cortex to open glands and peel away the medulla. Mince the 
medullae with a scalpel. 
3. Filter the medullae suspension through a nylon mesh and centrifuge the liquid at 
1000 rpm for 10 min. Discard supernatant. Resuspend pellet in isolation buffer. 
4. Make a mixture of buffer and percoll in a 1:9 ratio, add to the cell solution, and 
centrifuge at 18 °C at 13,000 rpm for 45 min. 
101 
 
5. The cells can now be separated using a pipette into fractions that are EP-secreting 
(dense band) and NE-secreting (light band).
130
 
 
Most of the cells in the dense fraction (~90%) are EP-secreting whereas only 
~67% of cells in the light band are NE-secreting. 
131
 The cells were cultured in Hibernate 
A media with calcium (Brain Bits, Springfield, IL), refrigerated, and used within 6 days 
of preparation.   
For the live cell imaging, approximately 5 mL of culture media containing either 
suspended NE or EP cells was centrifuged at 1000 rpm for 5 min and the supernatant 
discarded. Dulbecco’s modified Eagle’s medium (DMEM, 1 mL) was added, and the 
cells incubated on a Petri dish with sensor (0.1-10 µL) at physiological temperature for 
30 min. The cells were then transferred to a centrifuge tube, spun, washed twice with 
prewarmed PBS (Gibco, Grand Island, NY), then taken up in prewarmed chromaffin cell 
regular medium (DMEM with 10% (v/v) fetal bovine serum and 1% 
penicillin/streptomycin). To help the cells stick, they were plated onto coverslips coated 
with poly-lysine and incubated at 37 °C for 10 min. The coverslips were imaged using an 
Olympus Optical FluoView FV1000 confocal laser scanning biological microscope. A 
standard cell bath solution was added (150 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1.2 mM 
MgCl2, 10 mM HEPES, and 11 mM glucose, pH 7.2), and the images were acquired 
using a laser with a wavelength of either 488 or 440 nm. 
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Part VI. Synthetic Procedures and Characterization Data 
 
 
 
Sensor 14.  Compound 13 
132
 (200 mg, 0.715 mmol) and K2CO3 (395 mg, 2.860 mmol) 
were measured into a flame-dried round bottom flask.  To the starting material was added 
a 0.1 M solution of ethanethiol in DMF (6.9 mL).  The solution stirred at room 
temperature for 19 h.  The DMF was removed in vacuo and the remaining crude material 
was purified by chromatography (95:5 CH2Cl2/ EtOAc) to yield sensor 14 as a yellow oil 
(145 mg, 66%): 
1
H NMR (500 MHz, CDCl3) δ 10.31 (s, 1H), 8.01 (d, 1H, J = 9.5 Hz), 
6.60 (dd, 1H, J = 9.5, 2.5 Hz), 6.37 (d, 1H, J = 2.5 Hz), 3.43 (q, 4H, J = 7.5), 3.04 (q, 
2H, J = 7.5 Hz), 1.24 (t, 3H, J = 7.5 Hz), 1.21 (t, 6H, J = 7.5 Hz); 
13
C NMR (125 MHz, 
CDCl3) δ 188.2, 161.6, 160.5, 155.9, 153.0, 129.8, 113.8, 110.2, 109.7, 96.9, 45.1, 32.5, 
14.8, 12.5; IR (neat, cm
-1
) 2970, 2925, 2868, 1712, 1610, 1487, 1409, 1352, 1136; HRMS 
calculated for C16H19NNaO3S (M + Na
+
): 328.0983. Found: 328.0974. 
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Compound 40.  A mixture of compound 39 (129 mg, 0.541 mmol), PhB(OH)2 (79.1 mg, 
0.649 mmol), Pd2dba3 (24.7 mg, 0.027 mmol), SPhos (33.0 mg, 0.081 mmol), K3PO4(230 
mg, 1.082 mmol) degassed for 15 minutes.  Dry, degassed THF (3.2 mL) was added and 
the solution stirred at 60 °C for 12 h.  The solution was filtered and the solvent removed 
in vacuo.  The remaining residue was purified by chromatography (95:5 CH2Cl2/EtOAc) 
to yield compound 40 (107 mg, 71%) as a yellow solid (mp 164 °C): 
1
H NMR (500 MHz, 
CDCl3) δ 9.90 (s, 1H), 7.51-7.58 (m, 3H), 7.26-7.31 (m, 2H), 7.11 (d, 1H, J = 9.0 Hz), 
6.87 (d, 1H, J = 2.5 Hz), 6.78 (dd, 1H, J = 9.2, 2.5 Hz), 3.91 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 188.2, 165.4, 161.8, 158.7, 156.9, 132.0, 130.7, 129.7, 128.7, 128.4, 
115.9, 113.6, 113.3, 100.6, 56.1; IR (neat, cm
-1
) 2846, 1756, 1720, 1614, 1581, 1532, 
1374, 1296; HRMS calculated for C17H12O4Na (M + Na
+
): 303.0628. Found: 303.0628. 
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Compound 41.  A solution of compound 40 (38 mg, 0.136 mmol) in CH2Cl2 (2 mL) was 
added to a flame-dried round bottom and cooled to -78 °C.  BBr3 (0.68 mL of a 1.0 M 
solution in CH2Cl2, 0.678 mmol) was added dropwise.  The reaction was warmed to room 
temperature over 12 h.  After being quenched with cold deionized water (3 mL), the 
mixture was extracted with CH2Cl2 (10 mL x 5).  The combined organic layers were 
dried over Na2SO4, and the solvent was removed in vacuo.  The residue was purified by 
chromatography (7:3 hexanes/EtOAc) to yield compound 41 (21.7 mg, 60%) as a yellow 
solid (mp 165 °C): 
1
H NMR (500 MHz, d-acetone) δ 9.95 (s, 1H), 9.87 (s, 1H), 7.53-7.59 
(m, 3H), 7.35-7.41 (m, 2H), 7.03 (d, 1H, J = 7.5 Hz), 6.80-6.85 (m, 2H); 
13
C NMR (125 
MHz, d-acetone) δ 188.3, 164.7, 161.3, 159.3, 157.8, 133.9, 132.1, 129.9, 129.3, 116.5, 
114.7, 113.8, 103.4; IR (neat, cm
-1
) 3273, 1734, 16.14, 1535, 1385, 1120; HRMS 
calculated for C16H10O4Na (M + Na
+
): 289.0471. Found:  289.0471. 
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Compound 42.  Compound 41 (465 mg, 1.746 mmol) and N-phenyltriflimide (686 mg, 
1.921 mmol) were combined in a round bottom flask.  THF (24 mL) was added and then 
DIPEA was added dropwise (0.38 mL, 2.270 mmol).  The mixture stirred at ambient 
temperature for 3 h followed by removal of the solvent in vacuo.   The residue was 
purified by chromatography (95:5 CH2Cl2/EtOAc) to yield compound 42 (607.2 mg, 
87%) as a golden oil: 
1
H NMR (500 MHz, CDCl3) δ 9.95 (s, 1H), 7.56-7.62 (m, 3H), 
7.33-7.37 (m, 2H), 7.29-7.32 (m, 2H), 7.16 (dd, 1H, J = 9.0, 2.5 Hz); 
13
C NMR (125 
MHz, CDCl3) δ 187.5, 159.5, 157.1, 155.0, 152.6, 131.4, 130.8, 130.3, 129.0, 128.4, 
119.9, 119.7 (q, C-F, J = 40 Hz), 118.0, 117.3, 110.6; IR (neat, cm
-1
) 1765, 1605, 1552, 
1422, 1364, 1217, 1136, 1107, 980; HRMS calculated for C17H9F3O6SNa (M + Na
+
): 
420.9964. Found: 420.9961.  
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ES517.  Compound 42 (123 mg, 0.309 mmol) was combined with N,N-
dimethylsulfamide (42 mg, 0.340 mmol), Pd2dba3 (14 mg, 0.015 mmol), SPhos (18 mg, 
0.046 mmol), and K3PO4 (132 mg, 0.618 mmol) in a round bottom flask and degassed for 
20 min.  Dry degassed THF was added and the mixture was purged with N2 for 30 min 
followed by heating at 55 °C for 24 h.  The solvent was evaporated with a stream of N2, 
the crude product taken up in water (pH 5), and extracted with EtOAc (15 mL x 3).   
Purification by chromatography (95:5 CH2Cl2/EtOAc) gave ES517 (54 mg, 47%) as a 
yellow solid (mp 195 C): 
1
H NMR (500 MHz, CDCl3) δ 9.91 (s, 1H), 7.52-7.58 (m, 3H), 
7.27-7.31 (m, 2H), 7.19 (d, 1H, J = 2.0 Hz), 7.15 (d, 1H, J = 9.0 Hz), 6.93 (dd, 1H, J = 
9.0, 2.0 Hz), 2.93 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 188.2, 161.5, 158.4, 155.9, 
144.1, 131.6, 130.8, 129.9, 128.8, 128.4, 116.9, 115.1, 114.5, 104.8, 38.1; IR (KBr, cm
-1
) 
3260, 1732, 1610, 1528, 1377, 1140; HRMS calculated for C18H16N2O5SNa (M + Na
+
): 
395.0672. Found: 395.0670. 
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Compound 28. Compound 42 
121
 (84 mg, 0.211 mmol), methanesulfonamide (22.1 mg, 
.232 mmol), Pd2dba3 (10.1 mg, .011 mmol), SPhos (13.1 mg, .032 mmol), and K3PO4 (90 
mg, .422 mmol) were combined in a round bottom flask and degassed with N2 for 20 
min.  Dry degassed THF (1.5 mL) was added and the mixture stirred at 60 C for 18 h.  
The solvent was removed in vacuo.  The remaining residue was taken up in EtOAc, 
washed with a brine solution at pH 4 (10 mL), dried over MgSO4, and the solvent 
removed in vacuo.  Purification by chromatography (9:1 CH2Cl2/EtOAc) gave compound 
28 (24 mg, 33%) as a beige solid (decomp 238 C): 
1H NMR (500 MHz, DMSO) δ 10.77 
(s, 1H), 9.71 (s, 1H), 7.54-7.58 (m, 3H), 7.35-7.39 (m, 2H), 7.21 (d, 1H, J = 2.0 Hz), 7.11 
(dd, 1H, J = 9.0, 2.0 Hz), 7.06 (d, 1H, J = 9.0 Hz), 3.19 (s, 3H); 
13
C NMR (125 MHz, 
DMSO) δ 187.9, 160.3, 157.8, 155.3, 145.0, 131.9, 130.5, 129.4, 128.5, 128.5, 116.5, 
114.8, 114.3, 103.9, 40.3; IR (KBr, cm
-1
) 3436, 3289, 1753, 1614, 1536, 1373, 1160; 
HRMS calculated for C17H13NO5S (M + Na
+
): 366.0407. Found: 366.0405. 
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Compound 43.  Compound 42 (83.3 mg, .209 mmol) was combined with 
benzenesulfonamide (52.9 mg, .337 mmol), Pd2dba3 (13.7 mg, .015 mmol), SPhos (18.9 
mg, .046 mmol), and K3PO4 (130.1 mg, .613 mmol) in a round bottom flask and degassed 
for 20 min.  Dry degassed THF was added and the mixture was purged with N2 for 10 
min followed by heating at 55 C for 22 h.  The solvent was evaporated with a stream of 
N2, the crude product taken up in water (pH 4), and extracted with EtOAc (15 mL x 3).   
Purification by chromatography (95:5 CH2Cl2/EtOAc) gave compound 43 (61.8 mg, 
50%) as a yellow solid (decomp 233 C): 
1
H NMR (500 MHz, d-acetone) δ 9.85 (s, 1H), 
7.99 (d, 2H, J = 7.5 Hz), 7.67 (t, 1H, J = 7.5 Hz), 7.61 (t, 2H, J = 7.5 Hz), 7.52-7.57 (m, 
3H), 7.32-7.37 (m, 2H), 7.26 (d, 1H, J = 2.0 Hz), 7.15 (dd, 1H, J = 8.5, 2.0 Hz), 7.04 (d, 
1H, J = 8.5 Hz); 
13
C NMR (125 MHz, d-acetone) δ 206.2, 206.0, 188.2, 160.5, 158.8, 
156.4, 144.7, 140.3, 134.3, 133.3, 131.4, 130.3, 130.0, 129.2, 129.2, 128.0, 118.2, 116.4, 
115.7, 105.5; IR (KBr, cm
-1
) ; HRMS calculated for C22H15NO5S (M + Na
+
): 428.0563. 
Found: 428.0561. 
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Compound 44.  Compound 42 (83.3 mg, .209 mmol) was combined with 2-
thiophenesulfonamide (37.5 mg, .230 mmol), Pd2dba3 (9.2 mg, .010 mmol), SPhos (12.7 
mg, .031 mmol), and K3PO4 (89 mg, .418 mmol) in a round bottom flask and degassed 
for 20 min.  Dry degassed THF was added and the mixture was purged with N2 for 25 
min followed by heating at 55 C for 24 h.  The solvent was evaporated with a stream of 
N2, the crude product taken up in water (pH 5), and extracted with EtOAc (10 mL x 3).   
Purification by chromatography (95:5 CH2Cl2/EtOAc) gave compound 44 (42 mg, 49%) 
as a yellow solid (mp 195 C): 
1H NMR (500 MHz, DMSO) δ 11.48 (s, 1H), 9.68 (s, 1H), 
7.96 (d, 1H, J = 4.0 Hz), 7.77 (d, 1H, J = 3.0 Hz), 7.51-7.57 (m, 3H), 7.31-7.37 (m, 2H), 
7.13-7.18 (m, 2H), 7.10 (d, 1H, J = 9.0 Hz), 7.01 (d, 1H, J = 8.5 Hz); 
13
C NMR (125 
MHz, DMSO) δ 187.9, 160.0, 157.7, 155.0, 143.7, 139.3, 134.5, 133.6, 131.8, 130.4, 
129.4, 128.4, 128.0, 117.0, 115.0, 114.9, 104.3; IR (KBr, cm
-1
) 3240, 1740, 1610, 1532, 
1377, 1152, 1136; HRMS calculated for C20H13NO5S2 (M + Na
+
): 434.0127. Found: 
434.0125. 
 
 
 
 
 
 
117 
 
 
118 
 
 
 
 
 (53b). A mixture of 2,4-dihydroxy-3-methylbenzaldehyde (129 mg, 0.541 mmol), 
diethylglutaconate (1.22 mL, 6.901 mmol), piperidine (0.65 mL, 6.572 mmol), and 20 
mL EtOH was stirred in a round bottom flask at 60 °C for 5 h.  To the flask was added 3 
mL of 1 M HCl followed by removal of the solvent in vacuo.  Water (20 mL, pH 4) was 
added to the flask, it was gently swirled, and then vacuum filtered to yield compound 53b 
(1.787 g, 99%) as a pale yellow solid (mp 244 °C): 
1H NMR (500 MHz, DMSO) δ 10.81 
(s, 1H), 8.40 (s, 1H), 7.51 (d, 1H,  J = 16.0 Hz), 7.40 (d, 1H, J = 8.5 Hz), 6.89 (d, 1H, J 
= 8.5 Hz), 6.86 (d, 1H, J = 16.0 Hz), 4.17 (q, 2H, J = 7.0 Hz), 2.14 (s, 3H), 1.24 (t, 3H, J 
= 7.0 Hz); 
13
C NMR (125 MHz, DMSO)  166.3, 160.7, 159.4, 153.3, 146.0, 139.0, 
127.7, 119.6, 115.7, 112.9, 111.5, 110.6, 60.0, 14.2, 7.8; IR (neat, cm
-1
) 3240, 1716, 
1701, 1617, 1601, 1295, 1199, 977; HRMS calculated for C15H14O5 (M + Na
+
): 
297.0733. Found: 297.0730. 
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(54b). Compound 53b (200 mg, .729 mmol) and Ac2O (3.6 mL, 38.155 mmol) were 
combined in a 25 mL round bottom flask and stirred at room temperature for 10 min.  
Pyridine (3.6 mL, 44.511 mmol) was added dropwise, then the mixture stirred at room 
temperature for 23 h.  The contents of the flask were poured over ice chips and the white 
precipitate was vacuum filtered.  The remaining solid was purified via column 
chromatography (3:97 EtOAc/CH2Cl2) to yield compound 54b (161.5 mg, 70%) as a 
white solid (mp 154 °C): 
1
H NMR (500 MHz, DMSO) δ 8.54 (s, 1H), 7.61 (d, 1H, J = 
9.0 Hz), 7.55 (d, 1H, J = 16.0 Hz), 7.19 (d, 1H, J = 8.5 Hz), 6.95 (d, 1H, J = 16.0 Hz), 
4.19 (q, 2H, J = 7.0 Hz), 2.36 (s, 3H), 2.17 (s, 3H), 1.25 (t, 3H, J = 7.0 Hz); 
13
C NMR 
(125 MHz, DMSO) δ 168.6, 166.0, 158.7, 152.3, 152.1, 144.7, 138.1, 127.1, 121.7, 
120.1, 119.4, 118.2, 116.7, 60.2, 20.5, 14.1, 8.7; IR (KBr, cm
-1
) 1760, 1731, 1716, 1697, 
1694, 1198, 1156; HRMS calculated for  C17H16O6 (M + Na
+
): 339.0839. Found: 
339.0084.  
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(55b). Compound 54b (1.00 g, 3.161 mmol) and 87 mL THF were added to a 250 mL 
flame-dried flask.  Added dropwise to the flask was a OsO4  (0.87 mL of 4% soln. in 
water, .3278 mmol).  The mixture was stirred at room temperature for 2 h.  Sodium 
periodate (1.487 g, 6.954 mmol) was added and the reaction stirred for 10 days.  The 
solvent was removed in vacuo, water (20 mL, pH 4) was added, and the product was 
extracted with EtOAc (50 mL x 3).  The organic layers were combined, dried over 
MgSO4, and the solvent was removed in vacuo.  The diol intermediate was separated 
from the product via column chromatography (2-50% EtOAc in CH2Cl2) to yield 
compound 55b (402.5 mg, 52%) as an off-white solid (mp 169 °C): 
1
H NMR (500 MHz, 
DMSO) δ 10.03 (s, 1H), 8.67 (s, 1H), 7.87 (d, 1H, J = 8.5 Hz), 7.23 (d, 1H, J = 8.5 Hz), 
2.37 (s, 3H), 2.18 (s, 3H); 
13C NMR (125 MHz, DMSO) δ 188.0, 168.5, 158.9, 154.0, 
153.8, 146.8, 129.3, 120.7, 119.7, 118.6, 116.1, 20.6, 8.7; IR (KBr, cm
-1
) 2852, 1761, 
1720, 1699, 1601, 1569, 1197, 1160, 1078; HRMS calculated for C13H10O5 (M + Na
+
): 
269.0420. Found: 269.0418. 
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(56b). Compound 55b (150 mg, .609 mmol), ammonium acetate (610 mg, 7.914 mmol), 
and 10 mL of a 4:1 MeOH/H2O solution were combined in a 25 mL round bottom flask.  
The mixture was stirred at room temperature for 10 h then poured over ice chips.  Water 
(10 mL, pH 4) was added and the precipitate was vacuum filtered.  The crude solid was 
purified via column chromatography (5:95 EtOAc/CH2Cl2) to give sensor 56b (62.1 mg, 
50%) as a pale yellow solid (mp 223 °C): 
1
H NMR (500 MHz, d-acetone) δ 10.09 (s, 
1H), 8.44 (s, 1H), 7.65 (d, 1H, J = 8.5 Hz), 7.00 (d, 1H, J = 8.5 Hz), 2.26 (s, 3H); 
13
C 
NMR (125 MHz, DMSO) 187.9, 162.8, 159.9, 155.3, 147.8, 130.4, 116.7, 113.3, 111.1, 
111.0, 7.8; IR (KBr, cm
-1
) 3269, 1708, 1687, 1604, 1574, 1499, 1320; HRMS calculated 
for C11H8O4 (M + Na
+
): 227.0315. Found: 227.0313. 
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(53c).  To a 50 mL round bottom flask were added 4,6-dihydroxy-2,3-benzaldehyde (833 
mg, 5.013 mmol), diethylglutaconate (0.93 mL, 5.264 mmol), piperidine (0.5 mL, 5.013 
mmol), and 15 mL EtOH.  The mixture stirred at 55 °C for 4 h followed by the addition 
of 4 mL of 1 M HCl.  The solvent was removed in vacuo.  Water (20 mL, pH 4) was 
added and the solid was vacuum filtered to yield compound 53c (1.044 g, 72%) as a 
bright yellow solid (mp 202 °C): 
1
H NMR (500 MHz, DMSO)  10.86 (s, 1H), 8.64 (s, 
1H), 7.61 (d, 1H, J = 16.0 Hz), 6.94 (d, 1H, J = 16.0 Hz), 6.65 (s, 1H), 4.17 (q, 2H, J = 
7.0 Hz), 2.43 (s, 3H), 2.11 (s, 3H), 1.25 (t, 3H, J = 7.0 Hz); 
13
C NMR (125 MHz, 
DMSO)  166.5, 160.7, 159.1, 153.7, 144.1, 139.8, 137.3, 121.3, 119.3, 115.3, 110.7, 
99.1, 59.9, 14.6, 14.2, 11.6; IR (KBr, cm
-1
) 3203, 1709, 1699, 1684, 1595, 1567, 1282, 
1272, 1213; HRMS calculated for C16H16O5 (M + Na
+
): 311.0890. Found: 311.0887.  
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(54c). Compound 53c (1.044 g, 3.621 mmol) and Ac2O (18 mL, 190.773 mmol) were 
combined in a 50 mL round bottom flask and stirred at room temperature for 10 min.  
Pyridine (18 mL, 222.554 mmol) was added dropwise to the flask and the mixture was 
stirred at 50 °C for 1 h then at room temperature for 14 h.  The mixture was poured over 
ice chips and the precipitate was vacuum filtered to yield compound 54c (944.2 mg, 79%) 
as a pale yellow solid (mp 201 °C): 
1
H NMR (500 MHz, DMSO)  8.76 (s, 1H), 7.64 (d, 
1H, J = 16.0 Hz), 7.14 (s, 1H), 7.04 (d, 1H, J = 16.0 Hz), 4.19 (q, 2H, J = 7.0 Hz), 2.34 
(s, 3H), 2.09 (s, 3H), 1.26 (t, 3H, J = 7.0 Hz); 
13
C NMR (125 MHz, DMSO)  168.6, 
166.2, 158.6, 152.3, 152.0, 142.9, 138.9, 137.9, 126.1, 121.6, 119.7, 116.0, 107.9, 60.2, 
20.6, 14.9, 14.2, 12.3; IR (KBr, cm
-1
) 3105, 2978, 1762, 1721, 1622, 1310, 1296, 1212, 
1166, 1120; HRMS calculated for C18H18O6 (M + Na
+
): 353.0996. Found: 353.0991. 
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(55c).  Compound 54c (902 mg, 2.731 mmol), and 74 mL THF were combined in a 
flame-dried 200 mL round bottom flask.  Added dropwise to the flask was a OsO4  (0.75 
mL of 4% soln. in water, .123 mmol).  The mixture was stirred at room temperature for 
24 h.  Sodium periodate (1.285 g, 6.007 mmol) was added and the mixture stirred at room 
temperature for 6 days.  The solvent was removed in vacuo, water (20 mL, pH 4) was 
added, and the product was extracted with EtOAc (50 mL x 3).  The organic layers were 
combined, dried over MgSO4, and the solvent was removed in vacuo.  The product was 
purified via column chromatography (5:95 EtOAc/CH2Cl2) to yield compound 55c (266.8 
mg, 38%) as an off-white solid (decomp 183 °C): 
1
H NMR (500 MHz, DMSO)  10.03 
(s, 1H), 8.75 (s, 1H), 7.21 (s, 1H), 2.53 (s, 3H), 2.36 (s, 3H), 2.11 (s, 3H); 
13
C NMR (125 
MHz, DMSO)  188.2, 168.5, 158.5, 153.9, 153.8, 144.8, 139.9, 126.5, 120.2, 115.2, 
108.4, 20.6, 15.0, 12.3; IR (KBr, cm
-1
) 1761, 1732, 1720, 1695, 1601, 1565, 1189, 1119; 
HRMS calculated for C14H12O5 (M + Na
+
): 283.0577. Found: 283.0574. 
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ES470 (56c).  Compound 55c (100 mg, .384 mmol), ammonium acetate (610 mg, 7.914 
mmol), and 10 mL of a 4:1 MeOH/H2O solution were combined in a 25 mL round 
bottom flask and stirred at room temperature for 13 h.  The solvent was removed in 
vacuo, water (10 mL, pH 4) was added, and the product was extracted with EtOAc (15 
mL x 3).  The organic layers were combined, dried over MgSO4, and the solvent was 
removed in vacuo.  Purification using column chromatography (10:90 EtOAc/CH2Cl2) 
gave sensor ES470 (56c) (43 mg, 51%) as a yellow solid (decomp 199 °C): 
1
H NMR 
(500 MHz, DMSO)  11.30 (s, 1H), 9.96 (s, 1H), 6.68 (s, 1H), 2.45 (s, 3H), 2.11 (s, 3H); 
13
C NMR (125 MHz, DMSO)  187.9, 163.0, 159.4, 156.2, 145.2, 139.4, 122.0, 116.0, 
110.0, 99.5, 14.7, 11.5; IR (KBr, cm
-1
) 3481, 1724, 1667, 1589, 1377, 1287, 1217, 1168, 
764; HRMS calculated for C12H10O4 (M + Na
+
): 241.0471. Found 241.0470. 
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(53d).  2,4-Dihydroxy-3,5,6-trimethyl-benzaldehyde (695 mg, 3.857 mmol), diethyl 
glutaconate (0.72 mL, 4.050 mmol), piperidine (0.38 mL, 3.857 mmol), and 12 mL EtOH 
were combined in a 50 mL round bottom flask and stirred at 55 °C for 5 h then room 
temperature for 12 h.  The solvent was removed in vacuo and 5 mL of 1 M HCl was 
added.  The precipitate was vacuum filtered and rinsed with water (pH 4) to yield 
compound 53d (937 mg, 80%) as an orange solid (mp 212 °C): 
1
H NMR (500 MHz, 
DMSO)  9.64 (s, 1H), 8.64 (s, 1H), 7.62 (d, 1H, J = 16.0 Hz), 6.95 (d, 1H, J = 15.5 Hz), 
4.17 (q, 2H, J = 7.0 Hz), 2.41 (s, 3H), 2.19 (s, 3H), 2.16 (s, 3H), 1.25 (t, 3H, J = 7.0 Hz); 
13
C NMR (125 MHz, DMSO)  166.5, 159.2, 158.5, 151.7, 144.3, 139.8, 134.0, 121.3, 
119.4, 115.2, 111.0, 108.3, 59.9, 14.5, 14.2, 12.5, 8.5; IR (KBr, cm
-1
) 3420, 1691, 1577, 
1283, 1258, 1197, 1152; HRMS calculated for C17H18O5 (M + Na
+
): 325.1046. Found: 
325.1044. 
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(54d). Compound 53d (498 mg, 1.647 mmol) and Ac2O (8.2 mL, 86.908 mmol) were 
combined in a 25 mL round bottom flask.  Pyridine (8.2 mL, 101.386 mmol) was added 
dropwise to the flask.  The mixture stirred at 55 °C for 1 h then poured over ice chips.  
The precipitate was vacuum filtered to give compound 54d (522.5 mg, 92%) as an off-
white solid (mp 183 °C): 
1
H NMR (500 MHz, DMSO)  8.75 (s, 1H), 7.65 (d, 1H, J = 
16.0 Hz), 7.05 (d, 1H, J = 16.0 Hz), 4.19 (q, 2H, J = 7.0 Hz), 2.47 (s, 3H), 2.41 (s, 3H), 
2.12 (s, 3H), 2.08 (s, 3H), 1.26 (t, 3H, J = 7.0 Hz); 
13
C NMR (125 MHz, DMSO)  
168.4, 166.2, 158.5, 151.1, 150.4, 143.2, 138.9, 134.5, 125.8, 121.5, 119.4, 115.8, 115.3, 
60.2, 20.2, 14.6, 14.2, 12.7, 8.9; IR (KBr, cm
-1
) 1756, 1729, 1705, 1587, 1312, 1267, 
1209, 1175, 1130; HRMS calculated for C19H20O6 (M + Na
+
): 367.1152. Found: 
367.1148. 
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(55d). In a 200 mL round bottom flask, compound 54d (1133 mg, 3.290 mmol) was 
dissolved in 80 mL THF.  Added dropwise to the flask was a OsO4  (0.91 mL of 4% soln. 
in water, .148 mmol).  The mixture was stirred at room temperature for 13 h.  Sodium 
periodate (1.548 g, 7.238 mmol) was added and the mixture stirred at room temperature 
for 3 days.  The solvent was removed in vacuo, water (50 mL, pH 4) was added, and the 
product was extracted with EtOAc (50 mL x 3).  The organic layers were combined, 
dried over MgSO4, and the solvent was removed in vacuo to yield compound 55d (470 
mg, 52%) as an off-white solid (mp 172 °C): 
1
H NMR (500 MHz, CDCl3)  10.27 (s, 
1H), 8.70 (s, 1H), 2.52, (s, 3H), 2.41 (s, 3H), 2.25 (s, 3H), 2.16 (s, 3H); 
13
C NMR (125 
MHz, CDCl3)  188.1, 168.1, 160.1, 153.5, 153.4, 143.1, 136.2, 126.8, 119.8, 117.3, 
115.4, 20.4, 15.0, 13.1, 9.3; IR (KBr, cm
-1
) 1753, 1732, 1690, 1573, 1201, 1184, 1128; 
HRMS calculated for C15H14O5 (M + Na
+
): 297.0733. Found: 297.0730. 
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(56d). Compound 55d (50 mg, .182 mmol), HCl (4 M, 4 mL), AcOH (0.1 mL, 3.274 
mmol), and 2 mL H2O were combined in a 10 mL round bottom flask and refluxed for 
4.5 h.  Flask was sonicated as needed to break up solid chunks.  The flask was cooled in a 
0 °C ice bath followed by vacuum filtration of the precipitate which was rinsed with 
CH2Cl2 to remove any remaining starting material and yield sensor 56d (28 mg, 66%) as 
a yellow/green solid (mp 244°C): 
1
H NMR (500 MHz, DMSO)  10.09 (s, 1H), 9.98 (s, 
1H), 8.65 (s, 1H), 2.44 (s, 3H), 2.20 (s, 3H), 2.17 (s, 3H); 
13
C NMR (125 MHz, DMSO)  
188.0, 160.8, 159.5, 154.0, 145.4, 136.2, 121.9, 115.9, 110.3, 108.8, 14.5, 12.5, 8.5; IR 
(KBr, cm
-1
) 3391, 1732, 1675, 1565, 1348, 1225, 1193, 1148; HRMS calculated for 
C13H12O4 (M + Na
+
): 255.0628. Found: 255.0626. 
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